| Year |
Citation |
Score |
| 2020 |
Felix C, Baldeon ME, Zertuche F, Fornasini M, Paucar MJ, Ponce L, Rangarajan S, Yusuf S, Lopez-Jaramillo P. Low levels of awareness, treatment, and control of hypertension in Andean communities of Ecuador. Journal of Clinical Hypertension (Greenwich, Conn.). 22: 1530-1537. PMID 33245617 DOI: 10.1111/Jch.13982 |
0.336 |
|
| 2020 |
Sharma M, Hart RG, Smith EE, Bosch J, Eikelboom JW, Connolly SJ, Dyal L, Reeh KW, Casanova A, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, ... ... Yusuf S, et al. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy. Stroke. STROKEAHA120029762. PMID 32951537 DOI: 10.1161/Strokeaha.120.029762 |
0.302 |
|
| 2020 |
Bhavadharini B, Mohan V, Dehghan M, Rangarajan S, Swaminathan S, Rosengren A, Wielgosz A, Avezum A, Lopez-Jaramillo P, Lanas F, Dans AL, Yeates K, Poirier P, Chifamba J, Alhabib KF, ... ... Yusuf S, et al. White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries. Diabetes Care. PMID 32873587 DOI: 10.2337/Dc19-2335 |
0.302 |
|
| 2020 |
Oğuz A, Kılıçkap M, Güleç S, Altuntaş Y, Karşıdağ K, Temizhan A, Tümerdem BÇ, Keskinler MV, Rangarajan S, Yusuf S. The risk of cardiovascular events in patients with metabolic syndrome: The results of a population based prospective cohort study (PURE Turkey) Anatolian Journal of Cardiology. 24: 192-200. PMID 32870166 DOI: 10.14744/Anatoljcardiol.2020.27227 |
0.38 |
|
| 2020 |
Alhabib KF, Batais MA, Almigbal TH, Alshamiri MQ, Altaradi H, Rangarajan S, Yusuf S. Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: results from the Prospective Urban Rural Epidemiology study (PURE-Saudi). Bmc Public Health. 20: 1213. PMID 32770968 DOI: 10.1186/S12889-020-09298-W |
0.354 |
|
| 2020 |
Schwalm JD, McCready T, Islam S, McKee M, Yusuf S. Cardiovascular risk in hypertension: open questions about HOPE 4 - Authors' reply. Lancet (London, England). 396: 310-311. PMID 32738949 DOI: 10.1016/S0140-6736(20)30616-4 |
0.35 |
|
| 2020 |
Mancia G, Schumacher H, Böhm M, Mann JFE, Redon J, Facchetti R, Schmieder RE, Lonn EM, Teo KK, Yusuf S. Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. Journal of Hypertension. PMID 32694337 DOI: 10.1097/Hjh.0000000000002567 |
0.344 |
|
| 2020 |
Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, ... ... Yusuf S, et al. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. American Heart Journal. 227: 56-63. PMID 32679282 DOI: 10.1016/J.Ahj.2020.06.002 |
0.335 |
|
| 2020 |
Astrup A, Magkos F, Bier DM, Brenna JT, de Oliveira Otto MC, Hill JO, King JC, Mente A, Ordovas JM, Volek JS, Yusuf S, Krauss RM. Saturated Fats and Health: A Reassessment and Proposal for Food-based Recommendations: JACC State-of -the-Art Review. Journal of the American College of Cardiology. PMID 32562735 DOI: 10.1016/J.Jacc.2020.05.077 |
0.325 |
|
| 2020 |
Hystad P, Larkin A, Rangarajan S, AlHabib KF, Avezum Á, Calik KBT, Chifamba J, Dans A, Diaz R, du Plessis JL, Gupta R, Iqbal R, Khatib R, Kelishadi R, Lanas F, ... ... Yusuf S, et al. Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. Planetary Health. 4: e235-e245. PMID 32559440 DOI: 10.1016/S2542-5196(20)30103-0 |
0.336 |
|
| 2020 |
Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, et al. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients. Circulation. PMID 32546049 DOI: 10.1161/Circulationaha.120.046361 |
0.395 |
|
| 2020 |
Rajan S, McKee M, Rangarajan S, Bangdiwala S, Rosengren A, Gupta R, Kutty VR, Wielgosz A, Lear S, AlHabib KF, Co HU, Lopez-Jaramillo P, Avezum A, Seron P, Oguz A, ... ... Yusuf S, et al. Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries. Jama Psychiatry. PMID 32520341 DOI: 10.1001/Jamapsychiatry.2020.1351 |
0.306 |
|
| 2020 |
Aulin J, Hijazi Z, Siegbahn A, Andersson U, Alexander JH, Connolly SJ, Ezekowitz MD, Gersh BJ, Granger CB, Horowitz J, Hylek EM, Lopes RD, Yusuf S, Wallentin L, Oldgren J. Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials. Journal of Thrombosis and Haemostasis : Jth. PMID 32510737 DOI: 10.1111/Jth.14947 |
0.309 |
|
| 2020 |
Karthikeyan G, Connolly SJ, Ntsekhe M, Benz A, Rangarajan S, Lewis G, Yun Y, Sharma SK, Maklady F, Elghamrawy AE, Kazmi K, Cabral TTJ, Dayi H, Changsheng M, Gitura BM, ... ... Yusuf S, et al. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation. American Heart Journal. 225: 69-77. PMID 32474206 DOI: 10.1016/J.Ahj.2020.03.018 |
0.376 |
|
| 2020 |
López-Jaramillo P, López-López J, Yusuf S. Facing cardiovascular risk in Ibero-america. Revista Espanola De Cardiologia. 73: 799-801. PMID 32451224 DOI: 10.1016/J.Rec.2020.02.014 |
0.325 |
|
| 2020 |
Walli-Attaei M, Joseph P, Rosengren A, Chow CK, Rangarajan S, Lear SA, AlHabib KF, Davletov K, Dans A, Lanas F, Yeates K, Poirier P, Teo KK, Bahonar A, Camilo F, ... ... Yusuf S, et al. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London, England). PMID 32445693 DOI: 10.1016/S0140-6736(20)30543-2 |
0.372 |
|
| 2020 |
Steffel J, Eikelboom JW, Anand SS, Shestakovska O, Yusuf S, Fox KAA. The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared to Aspirin in Patients Chronic Vascular Disease. Circulation. PMID 32436455 DOI: 10.1161/Circulationaha.120.046048 |
0.434 |
|
| 2020 |
de Souza RJ, Dehghan M, Mente A, Bangdiwala SI, Ahmed SH, Alhabib KF, Altuntas Y, Basiak-Rasała A, Dagenais GR, Diaz R, Amma LI, Kelishadi R, Khatib R, Lear SA, Lopez-Jaramillo P, ... ... Yusuf S, et al. Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) study. The American Journal of Clinical Nutrition. PMID 32433740 DOI: 10.1093/Ajcn/Nqaa108 |
0.388 |
|
| 2020 |
Cunningham JW, Vaduganathan M, Claggett BL, John JE, Desai AS, Lewis EF, Zile MR, Carson P, Jhund PS, Kober L, Pitt B, Shah SJ, Swedberg K, Anand IS, Yusuf S, et al. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials. Jacc. Heart Failure. PMID 32387067 DOI: 10.1016/J.Jchf.2020.02.007 |
0.316 |
|
| 2020 |
Böhm M, Brueckmann M, Eikelboom JW, Ezekowitz M, Fräßdorf M, Hijazi Z, Hohnloser SH, Mahfoud F, Schmieder RE, Schumacher H, Wallentin L, Yusuf S. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial. European Heart Journal. PMID 32385506 DOI: 10.1093/Eurheartj/Ehaa247 |
0.392 |
|
| 2020 |
Bhatt DL, Eikelboom JW, Connolly SJ, Steg PG, Anand SS, Verma S, Branch KRH, Probstfield J, Bosch J, Shestakovska O, Szarek M, Maggioni AP, Widimský P, Avezum A, Diaz R, ... ... Yusuf S, et al. The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial. Circulation. PMID 32223318 DOI: 10.1161/Circulationaha.120.046448 |
0.371 |
|
| 2020 |
Kloosterman M, Oldgren J, Conen D, Wong JA, Connolly SJ, Avezum A, Yusuf S, Ezekowitz MD, Wallentin L, Ntep-Gweth M, Joseph P, Barrett TW, Tanosmsup S, McIntyre WF, Lee SF, et al. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 32215649 DOI: 10.1093/Europace/Euz360 |
0.319 |
|
| 2020 |
Bainey KR, Welsh RC, Connolly SJ, Marsden T, Bosch J, Fox KAA, Steg PG, Vinereanu D, Connolly DL, Berkowitz SD, Foody JM, Probstfield JL, Branch KR, Lewis BS, Diaz R, ... ... Yusuf S, et al. Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients with Prior Percutaneous Coronary Intervention (COMPASS-PCI). Circulation. PMID 32178526 DOI: 10.1161/Circulationaha.119.044598 |
0.313 |
|
| 2020 |
Murphy A, Palafox B, Walli-Attaei M, Powell-Jackson T, Rangarajan S, Alhabib KF, Avezum AJ, Calik KBT, Chifamba J, Choudhury T, Dagenais G, Dans AL, Gupta R, Iqbal R, Kaur M, ... ... Yusuf S, et al. The household economic burden of non-communicable diseases in 18 countries. Bmj Global Health. 5: e002040. PMID 32133191 DOI: 10.1136/Bmjgh-2019-002040 |
0.326 |
|
| 2020 |
Anand SS, Friedrich MG, Desai D, Schulze KM, Awadalla P, Busseuil D, Dummer TJB, Jacquemont S, Dick A, Kelton D, Kirpalani A, Lear SA, Leipsic J, Noseworthy MD, Parker L, ... ... Yusuf S, et al. Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury. Stroke. STROKEAHA119028179. PMID 32126938 DOI: 10.1161/Strokeaha.119.028179 |
0.311 |
|
| 2020 |
Sessler DI, Conen D, Leslie K, Yusuf S, Popova E, Graham M, Kurz A, Villar JC, Mrkobrada M, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Xavier D, et al. One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery. Anesthesiology. PMID 32022771 DOI: 10.1097/Aln.0000000000003158 |
0.342 |
|
| 2020 |
Farooqi MAM, Gerstein H, Yusuf S, Leong DP. Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals. Journal of the American Heart Association. 9: e014686. PMID 31986990 DOI: 10.1161/Jaha.119.014686 |
0.402 |
|
| 2020 |
Dehghan M, Mente A, Rangarajan S, Mohan V, Lear S, Swaminathan S, Wielgosz A, Seron P, Avezum A, Lopez-Jaramillo P, Turbide G, Chifamba J, AlHabib KF, Mohammadifard N, Szuba A, ... ... Yusuf S, et al. Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries. The American Journal of Clinical Nutrition. PMID 31965140 DOI: 10.1093/Ajcn/Nqz348 |
0.331 |
|
| 2020 |
McAlister FA, Mian R, Oldgren J, Wallentin L, Ezekowitz M, Yusuf S, Connolly SJ, Healey JS. Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study Plos One. 15. PMID 31940361 DOI: 10.1371/Journal.Pone.0226259 |
0.341 |
|
| 2019 |
Whiteley WN, Anand S, Bangdiwala SI, Bosch J, Canavan M, Chertkow H, Gerstein HC, Gorelick P, O'Donnell M, Paré G, Pigeyre M, Seshadri S, Sharma M, Smith EE, Williamson J, ... ... Yusuf S, et al. Are large simple trials for dementia prevention possible? Age and Ageing. PMID 31830268 DOI: 10.1093/Ageing/Afz152 |
0.34 |
|
| 2019 |
Gupta R, Yusuf S. Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs. Bmc Medicine. 17: 209. PMID 31767015 DOI: 10.1186/S12916-019-1454-Y |
0.367 |
|
| 2019 |
Vanassche T, Verhamme P, Anand SS, Shestakovska O, Fox KA, Bhatt DL, Avezum A, Alings M, Aboyans V, Maggioni AP, Widimsky P, Berkowitz SD, Yusuf S, Connolly SJ, Eikelboom JW, et al. Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial. European Journal of Preventive Cardiology. 2047487319882154. PMID 31615291 DOI: 10.1177/2047487319882154 |
0.381 |
|
| 2019 |
Anand SS, Tu JV, Desai D, Awadalla P, Robson P, Jacquemont S, Dummer T, Le N, Parker L, Poirier P, Teo K, Lear SA, Yusuf S, Tardif JC, Marcotte F, et al. Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease. European Heart Journal Cardiovascular Imaging. PMID 31565735 DOI: 10.1093/Ehjci/Jez226 |
0.336 |
|
| 2019 |
Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C, Berkowitz SD, Cook Bruns N, Muehlhofer E, ... ... Yusuf S, et al. Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin. Journal of the American College of Cardiology. 74: 1519-1528. PMID 31537259 DOI: 10.1016/J.Jacc.2019.07.065 |
0.32 |
|
| 2019 |
Perera KS, Ng KKH, Nayar S, Catanese L, Dyal L, Sharma M, Connolly SJ, Yusuf S, Bosch J, Eikelboom JW, Hart RG. Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial. Jama Neurology. PMID 31524941 DOI: 10.1001/Jamaneurol.2019.2984 |
0.352 |
|
| 2019 |
Ferguson J, O'Leary N, Maturo F, Yusuf S, O'Donnell M. Graphical comparisons of relative disease burden across multiple risk factors. Bmc Medical Research Methodology. 19: 186. PMID 31506063 DOI: 10.1186/S12874-019-0827-4 |
0.351 |
|
| 2019 |
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London, England). PMID 31492503 DOI: 10.1016/S0140-6736(19)32008-2 |
0.398 |
|
| 2019 |
Whitlock RP, Dieleman JM, Belley-Cote E, Vincent J, Zhang M, Devereaux PJ, Kalkman CJ, van Dijk D, Yusuf S. The Effect of Steroids in Patients Undergoing Cardiopulmonary Bypass: An Individual Patient Meta-Analysis of Two Randomized Trials. Journal of Cardiothoracic and Vascular Anesthesia. PMID 31401207 DOI: 10.1053/J.Jvca.2019.06.012 |
0.314 |
|
| 2019 |
Joshi R, Agrawal T, Fathima F, Usha T, Thomas T, Misquith D, Kalantri S, Chidambaram N, Raj T, Singamani A, Hegde S, Xavier D, Devereaux PJ, Pais P, Gupta R, ... Yusuf S, et al. Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial. American Heart Journal. 216: 9-19. PMID 31377568 DOI: 10.1016/J.Ahj.2019.06.007 |
0.36 |
|
| 2019 |
Leong DP, McMurray JJV, Joseph PG, Yusuf S. From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5). Journal of the American College of Cardiology. 74: 683-698. PMID 31370961 DOI: 10.1016/J.Jacc.2019.04.068 |
0.315 |
|
| 2019 |
Anand SS, Eikelboom JW, Dyal L, Bosch J, Neumann C, Widimsky P, Avezum AA, Probstfield J, Cook Bruns N, Fox KAA, Bhatt DL, Connolly SJ, Yusuf S. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial. Journal of the American College of Cardiology. 73: 3271-3280. PMID 31248548 DOI: 10.1016/J.Jacc.2019.02.079 |
0.373 |
|
| 2019 |
Conen D, Alonso-Coello P, Douketis J, Chan MTV, Kurz A, Sigamani A, Parlow JL, Wang CY, Villar JC, Srinathan SK, Tiboni M, Malaga G, Guyatt G, Sivakumaran S, Rodriguez Funes MV, ... ... Yusuf S, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. European Heart Journal. PMID 31237939 DOI: 10.1093/Eurheartj/Ehz431 |
0.332 |
|
| 2019 |
Mente A, O'Donnell MJ, Yusuf S. Letter by Mente et al Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease". Hypertension (Dallas, Tex. : 1979). 74: e26. PMID 31230541 DOI: 10.1161/Hypertensionaha.119.13321 |
0.341 |
|
| 2019 |
Aguirre Dávila L, Weber K, Bavendiek U, Bauersachs J, Wittes J, Yusuf S, Koch A. Digoxin-mortality: randomized vs. observational comparison in the DIG trial. European Heart Journal. PMID 31211324 DOI: 10.1093/Eurheartj/Ehz395 |
0.325 |
|
| 2019 |
Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S. Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial. Circulation. PMID 31163978 DOI: 10.1161/Circulationaha.119.039609 |
0.344 |
|
| 2019 |
Cairns JA, Eikelboom JW, Shestakovska O, Yusuf S, DeMets D. Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent. Journal of the American College of Cardiology. 73: 2769-2772. PMID 31146821 DOI: 10.1016/J.Jacc.2019.03.479 |
0.301 |
|
| 2019 |
Fox KAA, Eikelboom JW, Shestakovska O, Connolly SJ, Metsarinne KP, Yusuf S. Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial. Journal of the American College of Cardiology. 73: 2243-2250. PMID 31072566 DOI: 10.1016/J.Jacc.2019.02.048 |
0.375 |
|
| 2019 |
Hystad P, Duong M, Brauer M, Larkin A, Arku R, Kurmi OP, Fan WQ, Avezum A, Azam I, Chifamba J, Dans A, du Plessis JL, Gupta R, Kumar R, Lanas F, ... ... Yusuf S, et al. Health Effects of Household Solid Fuel Use: Findings from 11 Countries within the Prospective Urban and Rural Epidemiology Study. Environmental Health Perspectives. 127: 57003. PMID 31067132 DOI: 10.1289/Ehp3915 |
0.307 |
|
| 2019 |
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, ... ... Yusuf S, et al. Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial. Gastroenterology. PMID 31054846 DOI: 10.1053/J.Gastro.2019.04.041 |
0.351 |
|
| 2019 |
Khunti K, Jung H, Dans AL, Held C, Dagenais GR, Yusuf S, Lonn E. Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients. The Canadian Journal of Cardiology. 35: 644-652. PMID 31030865 DOI: 10.1016/J.Cjca.2019.03.002 |
0.384 |
|
| 2019 |
Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, ... ... Yusuf S, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. The Lancet. Global Health. PMID 31028013 DOI: 10.1016/S2214-109X(19)30045-2 |
0.392 |
|
| 2019 |
Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, ... ... Yusuf S, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV (PURE): an international, community-based cohort study. The Lancet. Global Health. 7: e613-e623. PMID 31000131 DOI: 10.1016/S2214-109X(19)30070-1 |
0.331 |
|
| 2019 |
Loeb M, Dokainish H, Dans A, Palileo-Villanueva LM, Roy A, Karaye K, Zhu J, Liang Y, Goma F, Damasceno A, AlHabib KF, Yonga G, Mondo C, Almahmeed W, Al Mulla A, ... Yusuf S, et al. Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design. American Heart Journal. 212: 36-44. PMID 30933856 DOI: 10.1016/J.Ahj.2019.02.009 |
0.302 |
|
| 2019 |
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. European Heart Journal. PMID 30919899 DOI: 10.1093/Eurheartj/Ehz149 |
0.338 |
|
| 2019 |
Alak A, Hohnloser SH, Fräßdorf M, Reilly P, Ezekowitz M, Healey JS, Brueckmann M, Yusuf S, Connolly SJ. Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial. Europace. 21: 1023-1030. PMID 30848783 DOI: 10.1093/Europace/Euz021 |
0.319 |
|
| 2019 |
Dagenais GR, Jung H, Bogaty P, Bosch J, Yusuf S, Gerstein HC. Basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycemia. An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) Trial. Diabetes, Obesity & Metabolism. PMID 30785660 DOI: 10.1111/Dom.13674 |
0.321 |
|
| 2019 |
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, Bowman L, Braunwald E, Byington R, Cannon C, Clearfield M, Colhoun H, Collins R, Dahlöf B, Davies K, ... ... Yusuf S, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials The Lancet. 393: 407-415. PMID 30712900 DOI: 10.1016/S0140-6736(18)31942-1 |
0.365 |
|
| 2019 |
Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, Catanese L, Keltai K, Aboyans V, Alings M, Ha JW, Varigos J, Tonkin A, O'Donnell M, Bhatt DL, ... ... Yusuf S, et al. Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial. Circulation. PMID 30667279 DOI: 10.1161/Circulationaha.118.035864 |
0.322 |
|
| 2019 |
Lamy A, Lonn E, Tong W, Swaminathan B, Jung H, Gafni A, Bosch J, Yusuf S. The cost implication of primary prevention in the HOPE 3 trial. European Heart Journal. Quality of Care & Clinical Outcomes. PMID 30657891 DOI: 10.1093/Ehjqcco/Qcz001 |
0.395 |
|
| 2019 |
Lamy A, Eikelboom J, Sheth T, Connolly S, Bosch J, Fox KAA, Zhu J, Lonn E, Dagenais G, Widimsky P, Branch KRH, Bhatt DL, Zheng Z, Straka Z, Dagenais F, ... ... Yusuf S, et al. Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study. Journal of the American College of Cardiology. 73: 121-130. PMID 30654882 DOI: 10.1016/J.Jacc.2018.10.048 |
0.363 |
|
| 2019 |
Hijazi Z, Verdecchia P, Oldgren J, Andersson U, Reboldi G, Di Pasquale G, Mazzotta G, Angeli F, Eikelboom JW, Ezekowitz MD, Connolly SJ, Yusuf S, Wallentin L. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial. Journal of the American Heart Association. 8: e010107. PMID 30651032 DOI: 10.1161/Jaha.118.010107 |
0.338 |
|
| 2019 |
Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A. Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials. Journal of Hypertension. 37: 16-23. PMID 30499920 DOI: 10.1097/Hjh.0000000000001994 |
0.302 |
|
| 2019 |
Pigeyre M, Sjaarda J, Chong M, Hess S, Bosch J, Yusuf S, Gerstein H, Pare G. 240-LB: Angiotensin-Converting Enzyme and Type 2 Diabetes Risk: A Mendelian Randomization Study Diabetes. 68. DOI: 10.2337/Db19-240-Lb |
0.33 |
|
| 2019 |
Bossard M, Yusuf S, Tanguay JF, Faxon DP, Boden WE, Steg PG, Granger C, Kastrati A, Budaj A, Pasquale GD, Valentin, Diaz R, Joyner C, Gao P, Mehta S. 2387Recurrent cardiovascular events and mortality in relation to antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease (MINOCA) European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz748.0145 |
0.335 |
|
| 2019 |
Benz A, Eikelboom J, Yusuf S, Hohnloser S, Beresh H, Ramakrishna K, Connolly SJ. Long-Term Treatment With Apixaban Of Participants Following Conclusion Of Averroes Journal of the American College of Cardiology. 73: 324. DOI: 10.1016/S0735-1097(19)30932-5 |
0.323 |
|
| 2019 |
Schwalm J, McCready T, Lamelas P, Islam S, Lear S, Garis L, Vincent K, Brooks D, Yusuf S. The Heart Outcomes Prevention Evaluation 4 Canada: A Pilot Study Of A Community-Based, Multi-Faceted Intervention, Led By Non-Physicians To Reduce Cardiovascular Risk In People With Hypertension Canadian Journal of Cardiology. 35. DOI: 10.1016/J.Cjca.2019.07.398 |
0.356 |
|
| 2019 |
Benz A, Healey J, Marsden T, Karthikeyan G, Hohnloser S, Oldgren J, Wallentin L, Ezekowitz M, Yusuf S, Connolly S. Stroke Risk Prediction In Patients With Atrial Fibrillation And Rheumatic Heart Disease: Results From The Re-Ly Af Registry Canadian Journal of Cardiology. 35. DOI: 10.1016/J.Cjca.2019.07.057 |
0.341 |
|
| 2019 |
Cunningham JW, Vaduganathan M, Claggett BL, John JE, Zile MR, Desai AS, Lewis EF, Pfeffer MA, Jhund PS, Kober L, Pitt B, Swedberg K, Anand IS, Yusuf S, McMurray JJV, et al. Prior and Incident Myocardial Infarction in HFpEF: A Pooled, Patient-Level Analysis of 3 Contemporary Clinical Trials with 8,916 Patients Journal of Cardiac Failure. 25. DOI: 10.1016/J.Cardfail.2019.07.214 |
0.388 |
|
| 2018 |
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. European Heart Journal. PMID 30590564 DOI: 10.1093/Eurheartj/Ehy808 |
0.34 |
|
| 2018 |
Pais P, Jung H, Dans A, Zhu J, Liu L, Kamath D, Bosch J, Lonn E, Yusuf S. Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study. European Journal of Preventive Cardiology. 2047487318819019. PMID 30537846 DOI: 10.1177/2047487318819019 |
0.351 |
|
| 2018 |
Camacho PA, Otero J, Pérez M, Arcos E, García H, Narvaez C, Molina DI, Sanchez G, Duran M, Cure C, Sotomayor A, Rico Á, Cotes F, Rangarajan S, Yusuf S, et al. The spectrum of the dyslipidemia in Colombia: The PURE study. International Journal of Cardiology. PMID 30463681 DOI: 10.1016/J.Ijcard.2018.10.090 |
0.387 |
|
| 2018 |
Joseph P, Pais P, Dans AL, Bosch J, Xavier D, Lopez-Jaramillo P, Yusoff K, Santoso A, Talukder S, Gamra H, Yeates K, Lopez PC, Tyrwhitt J, Gao P, Teo K, ... Yusuf S, et al. The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct. American Heart Journal. 206: 72-79. PMID 30342297 DOI: 10.1016/J.Ahj.2018.07.012 |
0.412 |
|
| 2018 |
Karthikeyan G, Devasenapathy N, Zühlke L, Engel ME, Rangarajan S, Teo KK, Mayosi BM, Yusuf S. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry. Heart (British Cardiac Society). PMID 30209123 DOI: 10.1136/Heartjnl-2018-313614 |
0.323 |
|
| 2018 |
Lamelas P, Schwalm JD, Leong D, Jolly S, Mehta S, Bangdiwala S, Yusuf S. Varying Effects of Body Mass Index and Mortality in Different Risk Groups. The American Journal of Cardiology. PMID 30107907 DOI: 10.1016/J.Amjcard.2018.06.038 |
0.346 |
|
| 2018 |
Sharma M, Hart RG, Smith EE, Bosch J, Yuan F, Casanova A, Eikelboom JW, Connolly SJ, Wong G, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, ... ... Yusuf S, et al. Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018784478. PMID 30058959 DOI: 10.1177/1747493018784478 |
0.31 |
|
| 2018 |
Dagenais GR, Jung H, Lonn E, Bogaty PM, Dehghan M, Held C, Avezum A, Jansky P, Keltai M, Leiter LA, Lopez-Jaramillo P, Toff WD, Bosch J, Yusuf S. Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial. Journal of the American Heart Association. 7. PMID 30033433 DOI: 10.1161/Jaha.118.008918 |
0.317 |
|
| 2018 |
Schwalm JR, McCready T, Lamelas P, Musa H, Lopez-Jaramillo P, Yusoff K, McKee M, Camacho PA, Lopez-Lopez J, Majid F, Thabane L, Islam S, Yusuf S. Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study. American Heart Journal. 203: 57-66. PMID 30015069 DOI: 10.1016/J.Ahj.2018.06.004 |
0.366 |
|
| 2018 |
Kent AP, Brueckmann M, Fraessdorf M, Connolly SJ, Yusuf S, Eikelboom JW, Oldgren J, Reilly PA, Wallentin L, Ezekowitz MD. Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation Journal of the American College of Cardiology. 72: 255-267. PMID 30012318 DOI: 10.1016/J.Jacc.2018.04.063 |
0.34 |
|
| 2018 |
Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, Xavier D, Szczeklik W, Meyhoff CS, Vincent J, Franzosi MG, Srinathan SK, Erb J, Magloire P, Neary J, ... ... Yusuf S, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet (London, England). 391: 2325-2334. PMID 29900874 DOI: 10.1016/S0140-6736(18)30832-8 |
0.343 |
|
| 2018 |
Böhm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder R, Weber M, Sliwa K, Williams B, Yusuf S. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. European Heart Journal. PMID 29873709 DOI: 10.1093/Eurheartj/Ehy287 |
0.382 |
|
| 2018 |
Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, ... ... Yusuf S, et al. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet (London, England). 391: 2019-2027. PMID 29864018 DOI: 10.1016/S0140-6736(18)30802-X |
0.303 |
|
| 2018 |
Dehghan M, Mente A, Yusuf S. Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple? - Authors' reply. Lancet (London, England). 391: 1681-1682. PMID 29726342 DOI: 10.1016/S0140-6736(18)30774-8 |
0.333 |
|
| 2018 |
Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Yusuf S, Wallentin L. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis American Heart Journal. 198: 169-177. PMID 29653640 DOI: 10.1016/J.Ahj.2017.10.015 |
0.316 |
|
| 2018 |
Teo K, Yusuf S. Polypill variants (Quarter Pill Trials). American Journal of Hypertension. PMID 29554202 DOI: 10.1093/Ajh/Hpy040 |
0.362 |
|
| 2018 |
Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, ... Yusuf S, et al. Major Adverse Limb Events in Lower Extremity Peripheral Artery Disease: COMPASS Trial. Journal of the American College of Cardiology. PMID 29540326 DOI: 10.1016/J.Jacc.2018.03.008 |
0.353 |
|
| 2018 |
Murphy A, Palafox B, O'Donnell O, Stuckler D, Perel P, AlHabib KF, Avezum A, Bai X, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Dans AL, Diaz R, Erbakan AN, ... ... Yusuf S, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. The Lancet. Global Health. 6: e292-e301. PMID 29433667 DOI: 10.1016/S2214-109X(18)30031-7 |
0.307 |
|
| 2018 |
Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, Swedberg K, Yusuf S, Granger CB, Pfeffer MA, McMurray JJV, Solomon SD. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. European Journal of Heart Failure. PMID 29431256 DOI: 10.1002/Ejhf.1149 |
0.307 |
|
| 2018 |
Duceppe E, Yusuf S, Tandon V, Rodseth R, Biccard BM, Xavier D, Szczeklik W, Meyhoff CS, Franzosi MG, Vincent J, Srinathan SK, Parlow J, Magloire P, Neary J, Rao M, et al. Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). The Canadian Journal of Cardiology. PMID 29398173 DOI: 10.1016/J.Cjca.2018.01.020 |
0.305 |
|
| 2018 |
Kruger PC, Eikelboom JW, Yusuf S. Rivaroxaban with or without aspirin for prevention of cardiovascular disease. Coronary Artery Disease. PMID 29346127 DOI: 10.1097/Mca.0000000000000605 |
0.311 |
|
| 2018 |
Jolly SS, Gao P, Cairns JA, Yusuf S, Bhatt DL, Wyse DG, Wells GA, Džavík V. Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI). Circulation. 137: 206-209. PMID 29311352 DOI: 10.1161/Circulationaha.117.030656 |
0.438 |
|
| 2018 |
Elmariah S, Doros G, Benavente OR, Bhatt DL, Connolly SJ, Yusuf S, Steinhubl SR, Liu Y, Hsieh WH, Yeh RW, Mauri L. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis. Circulation. Cardiovascular Interventions. 11: e005795. PMID 29311290 DOI: 10.1161/Circinterventions.117.005795 |
0.35 |
|
| 2018 |
Gerstein HC, Jung H, Rydén L, Diaz R, Gilbert RE, Yusuf S. Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention). Circulation. 137: 88-90. PMID 29279340 DOI: 10.1161/Circulationaha.117.030924 |
0.354 |
|
| 2018 |
Joseph P, Lonn E, Bosch J, Lopez P, Zhu J, Keltai M, Dans A, Reid C, Khunti K, Toff W, Piegas L, Kim JH, Swaminathan B, Bohm M, Yusuf S, et al. Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial. The Canadian Journal of Cardiology. 34: 38-44. PMID 29275880 DOI: 10.1016/J.Cjca.2017.09.026 |
0.34 |
|
| 2018 |
Wolsk E, Claggett B, Køber L, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. European Journal of Heart Failure. 20: 504-510. PMID 29193462 DOI: 10.1002/Ejhf.1073 |
0.404 |
|
| 2018 |
Verdecchia P, Reboldi G, Angeli F, Mazzotta G, Lip GYH, Brueckmann M, Kleine E, Wallentin L, Ezekowitz MD, Yusuf S, Connolly SJ, Pasquale GD. Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. Europace. 20: 253-262. PMID 28520924 DOI: 10.1093/Europace/Eux022 |
0.371 |
|
| 2018 |
Murphy A, Palafox B, Powell-Jackson T, Walli-Attaei M, Rangarajan S, Yusuf S, McKee M, Hanson K. Financial risk for people living with non-communicable diseases from 18 countries in the PURE study European Journal of Public Health. 28. DOI: 10.1093/Eurpub/Cky212.247 |
0.345 |
|
| 2018 |
Yusuf S. Improving worldwide access to inexpensive and effective treatments for common cardiovascular diseases European Heart Journal. 20. DOI: 10.1093/Eurheartj/Suy005 |
0.322 |
|
| 2018 |
Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, McKee M, Yusuf S. P3410Variations in socioeconomic status and cardiovascular disease: risk factors,incidence and case fatality. Rates and management in 20 countries European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy563.P3410 |
0.342 |
|
| 2018 |
Murphy A, Palafox B, Powell-Jackson T, Walli-Attaei M, Rangarajan S, Yusuf S, McKee M, Hanson K. MS06.2 Financial Risk For People Living With Non-communicable Diseases: An Analysis of Households From 18 Countries In the Pure Study Global Heart. 13: 380. DOI: 10.1016/J.Gheart.2018.09.023 |
0.311 |
|
| 2017 |
Darmon A, Bhatt DL, Elbez Y, Aboyans V, Anand S, Bosch J, Branch KR, Connolly SJ, Dyal L, Eikelboom JW, Fox KAA, Keltai K, Probstfield J, Yusuf S, Abtan J, et al. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry. European Heart Journal. PMID 29186454 DOI: 10.1093/Eurheartj/Ehx658 |
0.342 |
|
| 2017 |
Bossard M, Granger CB, Tanguay JF, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR. Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association. 6. PMID 29101117 DOI: 10.1161/Jaha.117.006577 |
0.36 |
|
| 2017 |
Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score. European Heart Journal. PMID 29069359 DOI: 10.1093/Eurheartj/Ehx584 |
0.345 |
|
| 2017 |
Joseph P, Yusuf S, Lee SF, Ibrahim Q, Teo K, Rangarajan S, Gupta R, Rosengren A, Lear SA, Avezum A, Lopez-Jaramillo P, Gulec S, Yusufali A, Chifamba J, Lanas F, et al. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart (British Cardiac Society). PMID 29066611 DOI: 10.1136/Heartjnl-2017-311609 |
0.323 |
|
| 2017 |
Proietti M, Hijazi Z, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Lane DA, Oldgren J, Roldan V, Yusuf S, Wallentin L. Comparison of Bleeding Risk Scores in Patients with Atrial Fibrillation:Insights from the RE-LY Trial. Journal of Internal Medicine. PMID 29044861 DOI: 10.1111/Joim.12702 |
0.351 |
|
| 2017 |
Mancia G, Schumacher H, Böhm M, Redon J, Schmieder RE, Verdecchia P, Sleight P, Teo K, Yusuf S. Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients. Hypertension (Dallas, Tex. : 1979). PMID 28974567 DOI: 10.1161/Hypertensionaha.117.09714 |
0.375 |
|
| 2017 |
Kristensen SL, Jhund PS, Lee MMY, Køber L, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, McMurray JJV. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes. Cardiovascular Drugs and Therapy. PMID 28948430 DOI: 10.1007/S10557-017-6754-X |
0.339 |
|
| 2017 |
Lamelas P, Schwalm JD, Quazi I, Mehta S, Devereaux PJ, Jolly S, Yusuf S. Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes. The American Journal of Cardiology. PMID 28916239 DOI: 10.1016/J.Amjcard.2017.07.043 |
0.385 |
|
| 2017 |
Platz E, Jhund PS, Claggett BL, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, McMurray JJ. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. European Journal of Heart Failure. PMID 28872259 DOI: 10.1002/Ejhf.901 |
0.301 |
|
| 2017 |
Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, ... ... Yusuf S, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet (London, England). PMID 28864332 DOI: 10.1016/S0140-6736(17)32252-3 |
0.312 |
|
| 2017 |
Miller V, Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G, Gupta R, Mohan V, Lear S, Bangdiwala SI, Schutte AE, Wentzel-Viljoen E, Avezum A, Altuntas Y, ... ... Yusuf S, et al. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet (London, England). PMID 28864331 DOI: 10.1016/S0140-6736(17)32253-5 |
0.309 |
|
| 2017 |
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, ... ... Yusuf S, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. The New England Journal of Medicine. PMID 28844192 DOI: 10.1056/Nejmoa1709118 |
0.381 |
|
| 2017 |
Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, Lopez-Jimenez F, Perel P, Santos R, Sniderman A, Sy R, Watts GF, Zhao D, Yusuf S, Wood D. World Heart Federation Cholesterol Roadmap. Global Heart. PMID 28765036 DOI: 10.1016/J.Gheart.2017.03.002 |
0.302 |
|
| 2017 |
Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Yusuf S, Siegbahn A, Wallentin L. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. American Heart Journal. 190: 94-103. PMID 28760218 DOI: 10.1016/J.Ahj.2017.06.001 |
0.319 |
|
| 2017 |
Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, ... ... Yusuf S, et al. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. The Canadian Journal of Cardiology. 33: 1027-1035. PMID 28754388 DOI: 10.1016/J.Cjca.2017.06.001 |
0.351 |
|
| 2017 |
Yacoub M, Mayosi B, ElGuindy A, Carpentier A, Yusuf S. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet (London, England). 390: 212-213. PMID 28721865 DOI: 10.1016/S0140-6736(17)31608-2 |
0.327 |
|
| 2017 |
Paparella D, Parolari A, Rotunno C, Vincent J, Myasoedova V, Guida P, De Palo M, Margari V, Devereaux PJ, Lamy A, Alamanni F, Yusuf S, Whitlock R. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy. Seminars in Thoracic and Cardiovascular Surgery. 29: 35-44. PMID 28683994 DOI: 10.1053/J.Semtcvs.2017.01.007 |
0.328 |
|
| 2017 |
Alonso-Coello P, Cook D, Xu SC, Sigamani A, Berwanger O, Sivakumaran S, Yang H, Xavier D, Martinez LX, Ibarra P, Rao-Melacini P, Pogue J, Zarnke K, Paniagua P, Ostrander J, ... Yusuf S, et al. Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study. Anesthesia and Analgesia. PMID 28622175 DOI: 10.1213/Ane.0000000000002111 |
0.303 |
|
| 2017 |
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, ... ... Yusuf S, et al. Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation. Current Problems in Cardiology. 42: 198-225. PMID 28552207 DOI: 10.1016/J.Cpcardiol.2017.03.001 |
0.354 |
|
| 2017 |
Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L, Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, ... ... Yusuf S, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. The Lancet. Global Health. PMID 28476564 DOI: 10.1016/S2214-109X(17)30196-1 |
0.355 |
|
| 2017 |
Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, et al. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. European Heart Journal. 38: 742-750. PMID 28426886 DOI: 10.1093/Eurheartj/Ehw509 |
0.349 |
|
| 2017 |
Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses from the Contemporary JUPITER and HOPE-3 Randomized Trials. Circulation. PMID 28385949 DOI: 10.1161/Circulationaha.117.028271 |
0.311 |
|
| 2017 |
Lauw MN, Eikelboom JW, Coppens M, Wallentin L, Yusuf S, Ezekowitz M, Oldgren J, Nakamya J, Wang J, Connolly SJ. Effects of dabigatran according to age in atrial fibrillation. Heart (British Cardiac Society). PMID 28213368 DOI: 10.1136/Heartjnl-2016-310358 |
0.313 |
|
| 2017 |
O'Donnell M, Yusuf S. The INTERSTROKE study on risk factors for stroke - Authors' reply. Lancet (London, England). 389: 36. PMID 28091375 DOI: 10.1016/S0140-6736(16)32614-9 |
0.306 |
|
| 2017 |
Hijazi Z, Oldgren J, Lindback J, Alexander J, Connolly S, Eikelboom J, Ezekowitz M, Hylek E, Lopes R, Yusuf S, Granger C, Siegbahn A, Wallentin L. 5770A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx493.5770 |
0.329 |
|
| 2016 |
O'Donnell M, Mann JF, Schutte AE, Staessen JA, Lopez-Jaramillo P, Thomas M, Mente A, Saulnier PJ, Yusuf S. Dietary Sodium and Cardiovascular Disease Risk. The New England Journal of Medicine. 375: 2404-2408. PMID 27974028 DOI: 10.1056/Nejmc1612304 |
0.368 |
|
| 2016 |
Mente A, O'Donnell MJ, Yusuf S. Sodium and cardiovascular disease - Authors' reply. Lancet (London, England). 388: 2113-2114. PMID 27968750 DOI: 10.1016/S0140-6736(16)31912-2 |
0.327 |
|
| 2016 |
Jolly SS, James SK, Džavík V, Cairns JA, Mahmoud KD, Zijlstra F, Yusuf S, Olivecrona GK, Renlund H, Gao P, Lagerqvist B, Alazzoni A, Kedev S, Stankovic G, Meeks B, et al. Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis. Circulation. PMID 27941066 DOI: 10.1161/Circulationaha.116.025371 |
0.333 |
|
| 2016 |
Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, Ismail N, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Diaz R, Gupta R, Iqbal R, Kaur M, ... ... Yusuf S, et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. International Journal For Equity in Health. 15: 199. PMID 27931255 DOI: 10.1186/S12939-016-0478-6 |
0.303 |
|
| 2016 |
Clase CM, Barzilay J, Gao P, Smyth A, Schmieder RE, Tobe S, Teo KK, Yusuf S, Mann JF. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney International. PMID 27927602 DOI: 10.1016/J.Kint.2016.09.038 |
0.384 |
|
| 2016 |
Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, Hartwig FP, Horta BL, Hyppönen E, Power C, Moldovan M, van Iperen E, Hovingh GK, Demuth I, Norman K, ... ... Yusuf S, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet. Diabetes & Endocrinology. PMID 27908689 DOI: 10.1016/S2213-8587(16)30396-5 |
0.321 |
|
| 2016 |
Yusufali A, Khatib R, Islam S, AlHabib K, Kelishadi R, Rangarajan S, Yusuf S. LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. Journal of Hypertension. 34: e551. PMID 27754306 DOI: 10.1097/01.Hjh.0000501507.52547.6E |
0.322 |
|
| 2016 |
Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Daniels R, Francis V, Ogendo S, Gitura B, Mondo C, Okello E, Lwabi P, ... ... Yusuf S, et al. Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low and Middle Income Countries: 2-Year Follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study). Circulation. PMID 27702773 DOI: 10.1161/Circulationaha.116.024769 |
0.355 |
|
| 2016 |
Camacho PA, Gomez-Arbelaez D, Molina DI, Sanchez G, Arcos E, Narvaez C, García H, Pérez M, Hernandez EA, Duran M, Cure C, Sotomayor A, Rico A, David TM, Cohen DD, ... ... Yusuf S, et al. Social disparities explain differences in hypertension prevalence, detection and control in Colombia. Journal of Hypertension. PMID 27662189 DOI: 10.1097/Hjh.0000000000001115 |
0.358 |
|
| 2016 |
Joseph PG, Pare G, Asma S, Engert JC, Yusuf S, Anand SS. Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations. The Canadian Journal of Cardiology. PMID 27650930 DOI: 10.1016/J.Cjca.2016.05.014 |
0.327 |
|
| 2016 |
Lonn EM, Yusuf S. Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3). Circulation. 134: 1311-1313. PMID 27619924 DOI: 10.1161/Circulationaha.116.023264 |
0.388 |
|
| 2016 |
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, ... ... Yusuf S, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet (London, England). PMID 27616593 DOI: 10.1016/S0140-6736(16)31357-5 |
0.371 |
|
| 2016 |
Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. PMID 27569438 DOI: 10.1161/Circulationaha.116.022802 |
0.32 |
|
| 2016 |
Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, Commerford P, Jansky P, Avezum A, Sigamani A, Demasceno A, Reilly P, Grinvalds A, Nakamya J, Aje A, ... ... Yusuf S, et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet (London, England). PMID 27515684 DOI: 10.1016/S0140-6736(16)30968-0 |
0.326 |
|
| 2016 |
Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). Circulation. 134: 589-98. PMID 27496855 DOI: 10.1161/Circulationaha.115.020950 |
0.329 |
|
| 2016 |
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, ... ... Yusuf S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet (London, England). PMID 27431356 DOI: 10.1016/S0140-6736(16)30506-2 |
0.326 |
|
| 2016 |
Mehta SR, Eikelboom JW, Rao-Melacini P, Weitz JI, Anand SS, Pare G, Budaj A, Pogue J, Fox KA, Yusuf S. A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. The Canadian Journal of Cardiology. PMID 27062239 DOI: 10.1016/J.Cjca.2016.01.029 |
0.359 |
|
| 2016 |
Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet (London, England). PMID 27056738 DOI: 10.1016/S0140-6736(16)00741-8 |
0.327 |
|
| 2016 |
Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, ... ... Yusuf S, et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. The New England Journal of Medicine. PMID 27041480 DOI: 10.1056/Nejmoa1600175 |
0.334 |
|
| 2016 |
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. The New England Journal of Medicine. PMID 27040132 DOI: 10.1016/J.Jvs.2016.07.054 |
0.387 |
|
| 2016 |
Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, et al. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. The New England Journal of Medicine. PMID 27039945 DOI: 10.1056/Nejmoa1600177 |
0.347 |
|
| 2016 |
Smyth A, Griffin M, Yusuf S, Mann JF, Reddan D, Canavan M, Newell J, O'Donnell M. Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. PMID 26975776 DOI: 10.1053/J.Jrn.2016.01.016 |
0.325 |
|
| 2016 |
Dagenais GR, Gerstein HC, Zhang X, McQueen M, Lear S, Lopez-Jaramillo P, Mohan V, Mony P, Gupta R, Kutty VR, Kumar R, Rahman O, Yusoff K, Zatonska K, Oguz A, ... ... Yusuf S, et al. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results from the Prospective Urban and Rural Epidemiology Study. Diabetes Care. PMID 26965719 DOI: 10.2337/Dc15-2338 |
0.306 |
|
| 2016 |
Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation. 133: 742-55. PMID 26903017 DOI: 10.1161/Circulationaha.115.008721 |
0.365 |
|
| 2016 |
Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, Gao P, Yusuf S, Mann JF, Oberbauer R. Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 26830448 DOI: 10.1053/J.Ajkd.2015.12.019 |
0.35 |
|
| 2016 |
Siegbahn A, Oldgren J, Andersson U, Ezekowitz MD, Reilly PA, Connolly SJ, Yusuf S, Wallentin L, Eikelboom JW. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy. Thrombosis and Haemostasis. 115: 921-30. PMID 26818781 DOI: 10.1160/Th15-07-0529 |
0.347 |
|
| 2016 |
Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, Wang X, Zhang H, Sun Y, Jia X, He X, Zhao X, Cheng X, Li J, Rangarajan S, ... ... Yusuf S, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. Journal of Hypertension. 34: 39-46. PMID 26630211 DOI: 10.1097/Hjh.0000000000000745 |
0.323 |
|
| 2016 |
Zamiri N, Eikelboom J, Reilly P, Ezekowitz M, Oldgren J, Yusuf S, Connolly S. Cha2Ds2-Vasc Versus Has-Bled Score For Predicting Risk Of Major Bleeding And Ischemic Stroke In Atrial Fibrillation: Insights From Re-Ly Trial Journal of the American College of Cardiology. 67: 1889. DOI: 10.1016/S0735-1097(16)31890-3 |
0.34 |
|
| 2016 |
Chatterjee P, Friedman KB, Kolb JM, Desai J, Wallentin L, Ezekowitz M, Yusuf S, Connolly S, Reilly P, Brueckmann M, Pogue J, Ilgenfritz J, Aisenberg J. 794 What is the Clinical Profile of “Life-Threatening” Gastrointestinal Bleeding in Anticoagulated Patients? A Sub-Analysis of the RE-LY Trial Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30649-7 |
0.309 |
|
| 2016 |
Paré G, McQueen M, Anand S, Clarke R, Koschinsky M, Yusuf S. PT073 Lipoprotein(A) and Risk of Myocardial Infarction in Major Ethnic Groups Global Heart. 11. DOI: 10.1016/J.Gheart.2016.03.480 |
0.32 |
|
| 2016 |
Sayed AE, Ibrahim AS, Elhassan HH, Zuhlke L, Engel M, Karthikeyan G, Teo K, Yusuf S, Mayosi B. PM276 The Global Rheumatic Heart Disease Study (Remedy) – Data From Sudan Global Heart. 11. DOI: 10.1016/J.Gheart.2016.03.405 |
0.301 |
|
| 2016 |
Joseph P, Yusuf S, Lee SF, Ibrahim Q, Teo K, Rangarajan S, Anand S. OC06_10 Applicability of a Non-Laboratory- and a Laboratory Based Cardiovascular Disease Risk Score Across Seven Regions of the World Global Heart. 11. DOI: 10.1016/J.Gheart.2016.03.029 |
0.349 |
|
| 2016 |
Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Gupta R, Vijayakumar K, Islam S, Rangarajan S, Yusuf S. OC05_03 Variations in Cardiovascular Disease Risk Factors and Outcomes in South Asia Global Heart. 11. DOI: 10.1016/J.Gheart.2016.03.018 |
0.323 |
|
| 2016 |
Wolsk E, Claggett B, Køber LV, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Extra-Cardiac Disease Burden Contributes More Than Cardiac Disease Burden to Risk of Cardiovascular Outcomes in Patient with Preserved Ejection Fraction Journal of Cardiac Failure. 22. DOI: 10.1016/J.Cardfail.2016.06.208 |
0.359 |
|
| 2015 |
Lamelas PM, Mente A, Diaz R, Orlandini A, Avezum A, Oliveira G, Lanas F, Seron P, Lopez-Jaramillo P, Camacho-Lopez P, O Donnell MJ, Rangarajan S, Teo K, Yusuf S. Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans. American Journal of Hypertension. PMID 26683344 DOI: 10.1093/Ajh/Hpv195 |
0.355 |
|
| 2015 |
Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L, Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, ... ... Yusuf S, et al. Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study. International Journal of Cardiology. 204: 133-141. PMID 26657608 DOI: 10.1016/J.Ijcard.2015.11.183 |
0.332 |
|
| 2015 |
Ng KH, Shestakovska O, Connolly SJ, Eikelboom JW, Avezum A, Diaz R, Lanas F, Yusuf S, Hart RG. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age and Ageing. PMID 26590293 DOI: 10.1093/Ageing/Afv156 |
0.344 |
|
| 2015 |
Yusuf S. A 35-year journey to evidence-based medicine: a personal story. European Heart Journal. 36: 3460-6. PMID 26586778 DOI: 10.1093/Eurheartj/Ehv566 |
0.394 |
|
| 2015 |
Gerstein HC, Paré G, McQueen MJ, Haenel H, Lee SF, Pogue J, Maggioni AP, Yusuf S, Hess S. Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia. Circulation. PMID 26518765 DOI: 10.1161/Circulationaha.115.015744 |
0.353 |
|
| 2015 |
Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear SA, Diaz R, Avezum A, ... ... Yusuf S, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet (London, England). PMID 26498706 DOI: 10.1016/S0140-6736(15)00469-9 |
0.334 |
|
| 2015 |
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, Kunti K, Kim JH, Leiter L, ... ... Yusuf S, et al. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics. The Canadian Journal of Cardiology. PMID 26481083 DOI: 10.1016/J.Cjca.2015.07.001 |
0.387 |
|
| 2015 |
Jolly SS, Cairns JA, Yusuf S, Rokoss MJ, Gao P, Meeks B, Kedev S, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemela K, Bernat I, Cantor WJ, et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet (London, England). PMID 26474811 DOI: 10.1016/S0140-6736(15)00448-1 |
0.366 |
|
| 2015 |
Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI, Shah PJ, ... ... Yusuf S, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 386: 1243-53. PMID 26460660 DOI: 10.1016/S0140-6736(15)00273-1 |
0.381 |
|
| 2015 |
Dokainish H, Teo K, Zhu J, Roy A, Al-Habib K, ElSayed A, Palileo L, Jaramillo PL, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Dorairaj P, ... ... Yusuf S, et al. Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). American Heart Journal. 170: 627-634.e1. PMID 26386785 DOI: 10.1016/J.Ahj.2015.07.008 |
0.348 |
|
| 2015 |
Nagarakanti R, Wallentin L, Noack H, Brueckmann M, Reilly P, Clemens A, Connolly SJ, Yusuf S, Ezekowitz MD. Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial). The American Journal of Cardiology. 116: 1204-9. PMID 26282726 DOI: 10.1016/J.Amjcard.2015.07.032 |
0.335 |
|
| 2015 |
Mente A, Chalcraft K, Ak H, Davis AD, Lonn E, Miller R, Potter MA, Yusuf S, Anand SS, McQueen MJ. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada. The Canadian Journal of Cardiology. 31: 1189-94. PMID 26239008 DOI: 10.1016/J.Cjca.2015.06.016 |
0.31 |
|
| 2015 |
Bekwelem W, Connolly SJ, Halperin JL, Adabag S, Duval S, Chrolavicius S, Pogue J, Ezekowitz MD, Eikelboom JW, Wallentin LG, Yusuf S, Hirsch AT. Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes. Circulation. 132: 796-803. PMID 26224811 DOI: 10.1161/Circulationaha.114.013243 |
0.329 |
|
| 2015 |
Perel P, Bianco E, Poulter N, Prabhakaran D, Pais P, Ralston J, Wood D, Yusuf S. Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and Conclusions. Global Heart. 10: 135-6. PMID 26213300 DOI: 10.1016/J.Gheart.2015.04.004 |
0.4 |
|
| 2015 |
Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, Wood D, Yusuf S. Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Global Heart. 10: 99-110. PMID 26213297 DOI: 10.1016/J.Gheart.2015.04.003 |
0.371 |
|
| 2015 |
Perel P, Bianco E, Poulter N, Prabhakaran D, Pais P, Ralston J, Wood D, Yusuf S. Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation Roadmap. Global Heart. 10: 97-8. PMID 26213296 DOI: 10.1016/J.Gheart.2015.04.002 |
0.339 |
|
| 2015 |
Yusuf S, Perel P, Wood D, Narula J. Reducing Cardiovascular Disease Globally: The World Heart Federation's Roadmaps. Global Heart. 10: 93-5. PMID 26213295 DOI: 10.1016/J.Gheart.2015.05.001 |
0.335 |
|
| 2015 |
Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, Gao P, Yusuf S, Mann JF, Oberbauer R. Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: iv76-85. PMID 26209742 DOI: 10.1093/Ndt/Gfv086 |
0.315 |
|
| 2015 |
Risso-Gill I, Balabanova D, Majid F, Ng KK, Yusoff K, Mustapha F, Kuhlbrandt C, Nieuwlaat R, Schwalm JD, McCready T, Teo KK, Yusuf S, McKee M. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. Bmc Health Services Research. 15: 254. PMID 26135302 DOI: 10.1186/S12913-015-0916-Y |
0.309 |
|
| 2015 |
Jolly SS, Cairns JA, Yusuf S, Meeks B, Gao P, Hart RG, Kedev S, Stankovic G, Moreno R, Horak D, Kassam S, Rokoss MJ, Leung RC, El-Omar M, Romppanen HO, et al. Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. European Heart Journal. 36: 2364-72. PMID 26129947 DOI: 10.1093/Eurheartj/Ehv296 |
0.31 |
|
| 2015 |
Brambatti M, Darius H, Oldgren J, Clemens A, Noack HH, Brueckmann M, Yusuf S, Wallentin L, Ezekowitz MD, Connolly SJ, Healey JS. Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. International Journal of Cardiology. 196: 127-131. PMID 26093161 DOI: 10.1016/J.Ijcard.2015.05.141 |
0.338 |
|
| 2015 |
Cukierman-Yaffe T, Anderson C, Teo K, Gao P, Gerstein HC, Yusuf S. Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies. The Journal of Clinical Endocrinology and Metabolism. 100: 2682-9. PMID 26020764 DOI: 10.1210/Jc.2015-1367 |
0.344 |
|
| 2015 |
Smyth A, Dehghan M, O'Donnell M, Anderson C, Teo K, Gao P, Sleight P, Dagenais G, Probstfield JL, Mente A, Yusuf S. Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries. Neurology. 84: 2258-65. PMID 25948720 DOI: 10.1212/Wnl.0000000000001638 |
0.301 |
|
| 2015 |
Yusuf S, Wood D, Ralston J, Reddy KS. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet. PMID 25892680 DOI: 10.1016/S0140-6736(15)60265-3 |
0.358 |
|
| 2015 |
Böhm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, Sliwa K, Schmieder RE, Sleight P, Yusuf S. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies. Journal of Internal Medicine. PMID 25872921 DOI: 10.1111/Joim.12373 |
0.36 |
|
| 2015 |
Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. The New England Journal of Medicine. 372: 1389-98. PMID 25853743 DOI: 10.1056/Nejmoa1415098 |
0.329 |
|
| 2015 |
Ross S, Gerstein HC, Eikelboom J, Anand SS, Yusuf S, Paré G. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. European Heart Journal. 36: 1454-62. PMID 25825043 DOI: 10.1093/Eurheartj/Ehv083 |
0.314 |
|
| 2015 |
Westenbrink BD, Alings M, Connolly SJ, Eikelboom J, Ezekowitz MD, Oldgren J, Yang S, Pongue J, Yusuf S, Wallentin L, Gilst WHv. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial Journal of Thrombosis and Haemostasis. 13: 699-707. PMID 25683276 DOI: 10.1111/Jth.12874 |
0.407 |
|
| 2015 |
Badar AA, Perez-Moreno AC, Hawkins NM, Brunton AP, Jhund PS, Wong CM, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Gardner RS, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. European Journal of Heart Failure. 17: 196-204. PMID 25678097 DOI: 10.1002/Ejhf.221 |
0.351 |
|
| 2015 |
Sandhu RK, Hohnloser SH, Pfeffer MA, Yuan F, Hart RG, Yusuf S, Connolly SJ, McAlister FA, Healey JS. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure Stroke; a Journal of Cerebral Circulation. 46: 667-672. PMID 25628308 DOI: 10.1161/Strokeaha.114.007140 |
0.349 |
|
| 2015 |
Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, Gao P, Gerstein H, Yusuf S, Oberbauer R, Mann JF. Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney International. 87: 784-91. PMID 25493953 DOI: 10.1038/Ki.2014.370 |
0.325 |
|
| 2015 |
Böhm M, Schumacher H, Schmieder RE, Mann JF, Teo K, Lonn E, Sleight P, Mancia G, Linz D, Mahfoud F, Ukena C, Sliwa K, Bakris G, Yusuf S. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. Journal of Internal Medicine. 278: 38-49. PMID 25431275 DOI: 10.1111/Joim.12333 |
0.369 |
|
| 2015 |
Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, Francis V, Ogendo S, Gitura B, Mondo C, Okello E, ... ... Yusuf S, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal. 36: 1115-22. PMID 25425448 DOI: 10.1093/Eurheartj/Ehu449 |
0.365 |
|
| 2015 |
Kristensen SL, Køber L, Jhund PS, Solomon SD, Kjekshus J, McKelvie RS, Zile MR, Granger CB, Wikstrand J, Komajda M, Carson PE, Pfeffer MA, Swedberg K, Wedel H, Yusuf S, et al. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation. 131: 43-53. PMID 25406306 DOI: 10.1161/Circulationaha.114.012284 |
0.352 |
|
| 2015 |
Vazir A, Claggett B, Jhund P, Castagno D, Skali H, Yusuf S, Swedberg K, Granger CB, McMurray JJ, Pfeffer MA, Solomon SD. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. European Heart Journal. 36: 669-75. PMID 25368202 DOI: 10.1093/Eurheartj/Ehu401 |
0.347 |
|
| 2015 |
Verdecchia P, Reboldi G, Angeli F, Trimarco B, Mancia G, Pogue J, Gao P, Sleight P, Teo K, Yusuf S. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 65: 108-14. PMID 25331850 DOI: 10.1161/Hypertensionaha.114.04310 |
0.391 |
|
| 2015 |
Hao G, Li W, Teo K, Wang X, Yang J, Wang Y, Liu L, Yusuf S. Influence of tea consumption on acute myocardial infarction in China population: the INTERHEART China study. Angiology. 66: 265-70. PMID 24755694 DOI: 10.1177/0003319714531849 |
0.328 |
|
| 2015 |
Rashid S, Sniderman A, Melone M, Brown PE, Otvos JD, Mente A, Schulze K, McQueen MJ, Anand SS, Yusuf S. Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians. European Journal of Preventive Cardiology. 22: 468-77. PMID 24659026 DOI: 10.1177/2047487314528461 |
0.33 |
|
| 2015 |
Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, Wood D, Yusuf S. Erratum: Reducing Premature Cardiovascular Morbidity and Mortality in People with Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease (Glob Heart (2015)10 (99-110)) Global Heart. 10. DOI: 10.1016/J.Gheart.2015.08.004 |
0.358 |
|
| 2014 |
Kamath DY, Xavier D, Gupta R, Devereaux PJ, Sigamani A, Hussain T, Umesh S, Xavier F, Girish P, George N, Thomas T, Chidambaram N, Joshi R, Pais P, Yusuf S. Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD). American Heart Journal. 168: 690-7. PMID 25440797 DOI: 10.1016/J.Ahj.2014.07.029 |
0.333 |
|
| 2014 |
Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L. Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis". Circulation. 130: e195. PMID 25421051 DOI: 10.1161/Circulationaha.114.012350 |
0.321 |
|
| 2014 |
Garg AX, Kurz A, Sessler DI, Cuerden M, Robinson A, Mrkobrada M, Parikh CR, Mizera R, Jones PM, Tiboni M, Font A, Cegarra V, Gomez MF, Meyhoff CS, VanHelder T, ... ... Yusuf S, et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. Jama. 312: 2254-64. PMID 25399007 DOI: 10.1001/Jama.2014.15284 |
0.346 |
|
| 2014 |
Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circulation. Heart Failure. 7: 895-902. PMID 25326006 DOI: 10.1161/Circheartfailure.114.001567 |
0.351 |
|
| 2014 |
O'Donnell M, Mente A, Yusuf S. Evidence relating sodium intake to blood pressure and CVD. Current Cardiology Reports. 16: 529. PMID 25297880 DOI: 10.1007/S11886-014-0529-9 |
0.328 |
|
| 2014 |
Connolly SJ, Wallentin L, Yusuf S. Additional Events in the RE-LY Trial The New England Journal of Medicine. 371: 1464-1465. PMID 25251519 DOI: 10.1056/Nejmc1407908 |
0.338 |
|
| 2014 |
McQueen MJ, Yusuf S. The Preventive Potential of Common, Easily Measured Risk Factors for Cardiovascular Disease Clinical Chemistry. 60: 1450-1451. PMID 25212762 DOI: 10.1373/Clinchem.2014.231274 |
0.359 |
|
| 2014 |
Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, ... ... Yusuf S, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. The New England Journal of Medicine. 371: 1121-30. PMID 25178809 DOI: 10.1056/Nejmoa1407380 |
0.333 |
|
| 2014 |
Marijon E, Heuzey JL, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S. Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study". Circulation. 130. PMID 25156923 DOI: 10.1161/Circulationaha.114.010275 |
0.35 |
|
| 2014 |
Joseph PG, O'Donnell MJ, Teo KK, Gao P, Anderson C, Probstfield JL, Bosch J, Khatib R, Yusuf S. The mini-mental state examination, clinical factors, and motor vehicle crash risk. Journal of the American Geriatrics Society. 62: 1419-26. PMID 25040793 DOI: 10.1111/Jgs.12936 |
0.342 |
|
| 2014 |
Schmieder RE, Schutte R, Schumacher H, Böhm M, Mancia G, Weber MA, McQueen M, Teo K, Yusuf S. Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia. 57: 2019-29. PMID 25037746 DOI: 10.1007/S00125-014-3330-9 |
0.322 |
|
| 2014 |
Gupta R, Islam S, Mony P, Kutty VR, Mohan V, Kumar R, Thakur J, Shankar VK, Mohan D, Vijayakumar K, Rahman O, Yusuf R, Iqbal R, Shahid M, Mohan I, ... ... Yusuf S, et al. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study. European Journal of Preventive Cardiology. PMID 24942224 DOI: 10.1177/2047487314540386 |
0.359 |
|
| 2014 |
Smyth A, Dunkler D, Gao P, Teo KK, Yusuf S, O'Donnell MJ, Mann JF, Clase CM. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney International. 86: 1205-12. PMID 24918156 DOI: 10.1038/Ki.2014.214 |
0.303 |
|
| 2014 |
Lip GYH, Eikelboom J, Yusuf S, Shestakovska O, Hart RG, Connolly S. Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study Stroke. 45: 2127-2130. PMID 24916911 DOI: 10.1161/Strokeaha.114.005746 |
0.377 |
|
| 2014 |
Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circulation. Heart Failure. 7: 590-5. PMID 24874200 DOI: 10.1161/Circheartfailure.113.001281 |
0.373 |
|
| 2014 |
Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Siegbahn A, Yusuf S, Wallentin L. Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy. Heart (British Cardiac Society). 100: 1193-200. PMID 24794140 DOI: 10.1136/Heartjnl-2013-304872 |
0.363 |
|
| 2014 |
Lopez-Jaramillo P, Cohen DD, Gómez-Arbeláez D, Bosch J, Dyal L, Yusuf S, Gerstein HC. Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial. International Journal of Cardiology. 174: 458-61. PMID 24768457 DOI: 10.1016/J.Ijcard.2014.04.013 |
0.335 |
|
| 2014 |
Whitlock R, Teoh K, Vincent J, Devereaux PJ, Lamy A, Paparella D, Zuo Y, Sessler DI, Shah P, Villar JC, Karthikeyan G, Urrútia G, Alvezum A, Zhang X, Abbasi SH, ... ... Yusuf S, et al. Rationale and design of the steroids in cardiac surgery trial. American Heart Journal. 167: 660-5. PMID 24766975 DOI: 10.1016/J.Ahj.2014.01.018 |
0.397 |
|
| 2014 |
Dokainish H, Rajaram M, Prabhakaran D, Afzal R, Orlandini A, Staszewsky L, Franzosi MG, Llanos J, Martinoli E, Roy A, Yusuf S, Mehta S, Lonn E. Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trial. Echocardiography (Mount Kisco, N.Y.). 31: 569-78. PMID 24702629 DOI: 10.1111/Echo.12452 |
0.402 |
|
| 2014 |
Bainey KR, Gafni A, Rao-Melacini P, Tong W, Steg PG, Faxon DP, Lamy A, Granger CB, Yusuf S, Mehta SR. The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study. Journal of Medical Economics. 17: 415-22. PMID 24702256 DOI: 10.3111/13696998.2014.911184 |
0.311 |
|
| 2014 |
Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, ... ... Yusuf S, et al. Aspirin in patients undergoing noncardiac surgery. The New England Journal of Medicine. 370: 1494-503. PMID 24679062 DOI: 10.1056/Nejmoa1401105 |
0.359 |
|
| 2014 |
Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, ... ... Yusuf S, et al. Clonidine in patients undergoing noncardiac surgery. The New England Journal of Medicine. 370: 1504-13. PMID 24679061 DOI: 10.1056/Nejmoa1401106 |
0.397 |
|
| 2014 |
Foulquier S, Böhm M, Schmieder R, Sleight P, Teo K, Yusuf S, Schumacher H, Unger T. Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: A Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis Journal of Hypertension. 32: 1334-1341. PMID 24621807 DOI: 10.1097/Hjh.0000000000000154 |
0.414 |
|
| 2014 |
Teo KK, Pfeffer M, Mancia G, O'Donnell M, Dagenais G, Diaz R, Dans A, Liu L, Bosch J, Joseph P, Copland I, Jung H, Pogue J, Yusuf S. Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European Heart Journal. 35: 1743-51. PMID 24616335 DOI: 10.1093/Eurheartj/Ehu079 |
0.303 |
|
| 2014 |
Jolly SS, Cairns J, Yusuf S, Meeks B, Shestakovska O, Thabane L, Niemelä K, Steg PG, Bertrand OF, Rao SV, Avezum A, Cantor WJ, Pancholy SB, Moreno R, Gershlick A, et al. Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI. American Heart Journal. 167: 315-321.e1. PMID 24576514 DOI: 10.1016/J.Ahj.2013.12.002 |
0.398 |
|
| 2014 |
Coppens M, Synhorst D, Eikelboom JW, Yusuf S, Shestakovska O, Connolly SJ. Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial European Heart Journal. 35: 1856-1863. PMID 24569032 DOI: 10.1093/Eurheartj/Ehu048 |
0.373 |
|
| 2014 |
Khatib R, Yusuf S, Barzilay JI, Papaioannou A, Thabane L, Gao P, Joseph PG, Teo K, Mente A. Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries. Age and Ageing. 43: 629-35. PMID 24554790 DOI: 10.1093/Ageing/Afu009 |
0.31 |
|
| 2014 |
Smyth A, O'Donnell MJ, Yusuf S, Clase CM, Teo KK, Canavan M, Reddan DN, Mann JF. Sodium intake and renal outcomes: a systematic review. American Journal of Hypertension. 27: 1277-84. PMID 24510182 DOI: 10.1093/Ajh/Hpt294 |
0.317 |
|
| 2014 |
Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure. European Journal of Heart Failure. 16: 325-33. PMID 24464788 DOI: 10.1002/Ejhf.23 |
0.39 |
|
| 2014 |
Rogers JK, Pocock SJ, McMurray JJV, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S. Analysing recurrent hospitalizations in heart failure: A review of statistical methodology, with application to CHARM-preserved European Journal of Heart Failure. 16: 33-40. PMID 24453096 DOI: 10.1002/Ejhf.29 |
0.339 |
|
| 2014 |
Verdecchia P, Reboldi G, Di Pasquale G, Mazzotta G, Ambrosio G, Yang S, Pogue J, Wallentin L, Ezekowitz MD, Connolly SJ, Yusuf S. Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study) American Journal of Cardiology. 113: 669-675. PMID 24359765 DOI: 10.1016/J.Amjcard.2013.10.045 |
0.39 |
|
| 2014 |
Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 103: 149-59. PMID 24356937 DOI: 10.1007/S00392-013-0644-4 |
0.408 |
|
| 2014 |
Lip GY, Clemens A, Noack H, Ferreira J, Connolly SJ, Yusuf S. Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database. Thrombosis and Haemostasis. 111: 933-42. PMID 24326736 DOI: 10.1160/Th13-09-0734 |
0.344 |
|
| 2014 |
Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis. Circulation. 129: 961-70. PMID 24323795 DOI: 10.1161/Circulationaha.113.003628 |
0.332 |
|
| 2014 |
Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D. Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. European Heart Journal. 35: 353-64. PMID 24288261 DOI: 10.1093/Eurheartj/Eht407 |
0.337 |
|
| 2014 |
Jolly SS, Cairns J, Yusuf S, Niemela K, Steg PG, Worthley M, Ferrari E, Cantor WJ, Fung A, Valettas N, Rokoss M, Olivecrona GK, Widimsky P, Cheema AN, Gao P, et al. Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention. Journal of the American College of Cardiology. 63: 954-63. PMID 24269362 DOI: 10.1016/J.Jacc.2013.10.052 |
0.328 |
|
| 2014 |
Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. European Journal of Preventive Cardiology. 21: 299-309. PMID 24191305 DOI: 10.1177/2047487313510678 |
0.396 |
|
| 2014 |
Reilly PA, Lehr T, Haertter S, Connolly SJ, Yusuf S, Eikelboom JW, Ezekowitz MD, Nehmiz G, Wang S, Wallentin L. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). Journal of the American College of Cardiology. 63: 321-8. PMID 24076487 DOI: 10.1016/J.Jacc.2013.07.104 |
0.309 |
|
| 2014 |
Kratz MT, Schumacher H, Sliwa K, Schmieder R, Pöss J, Mahfoud F, Unger T, Lonn E, Koon T, Mancia G, Sleight P, Yusuf S, Böhm M. Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients. European Journal of Preventive Cardiology. 21: 272-80. PMID 23818288 DOI: 10.1177/2047487313494835 |
0.368 |
|
| 2014 |
Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MRM, Yusufali AH, Hassan MO, Lewis BS, Islam S, Rangarajan S, Yusuf S. Association of risk factors with acute myocardial infarction in Middle Eastern countries: The INTERHEART Middle East study European Journal of Preventive Cardiology. 21: 400-410. PMID 23125402 DOI: 10.1177/2047487312465525 |
0.376 |
|
| 2014 |
Ezekowitz MD, Parise H, Nagarakanti R, Noack H, Brueckmann M, Clemens A, Reilly P, Connolly S, Yusuf S, Wallentin L. Comparison Of Dabigatran Versus Warfarin In Patients With Atrial Fibrillation And Valvular Heart Disease: The Re-Ly® Trial Journal of the American College of Cardiology. 63. DOI: 10.1016/S0735-1097(14)60325-9 |
0.376 |
|
| 2013 |
Sniderman AD, Islam S, Yusuf S, McQueen MJ. Is the superiority of apoB over non-HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables? Journal of Clinical Lipidology. 7: 626-631. PMID 24314360 DOI: 10.1016/J.Jacl.2013.08.004 |
0.325 |
|
| 2013 |
Devereaux PJ, Yusuf S. When It Comes to Trials, Do We Get What We Pay For? The New England Journal of Medicine. 369: 1962-1963. PMID 24224630 DOI: 10.1056/Nejme1310554 |
0.308 |
|
| 2013 |
Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S. Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation. 128: 2325-32. PMID 24081972 DOI: 10.1161/Circulationaha.113.002332 |
0.35 |
|
| 2013 |
Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 128: 2192-201. PMID 24016454 DOI: 10.1161/Circulationaha.112.000491 |
0.372 |
|
| 2013 |
Mellbin LG, Rydén L, Riddle MC, Probstfield J, Rosenstock J, DÃaz R, Yusuf S, Gerstein HC. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. European Heart Journal. 34: 3137-44. PMID 23999452 DOI: 10.1093/Eurheartj/Eht332 |
0.361 |
|
| 2013 |
Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JFE, Yusuf S, Oberbauer R. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus Jama Internal Medicine. 173: 1682-1692. PMID 23939297 DOI: 10.1001/Jamainternmed.2013.9051 |
0.33 |
|
| 2013 |
Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease American Heart Journal. 166: 306-314.e1. PMID 23895814 DOI: 10.1016/J.Ahj.2013.04.016 |
0.401 |
|
| 2013 |
Hohnloser SH, Shestakovska O, Eikelboom J, Franzosi MG, Tan RS, Zhu J, Yusuf S, Connolly SJ. The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial European Heart Journal. 34: 2752-2759. PMID 23892201 DOI: 10.1093/Eurheartj/Eht292 |
0.349 |
|
| 2013 |
Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). Journal of the American College of Cardiology. 62: 1845-54. PMID 23850914 DOI: 10.1016/J.Jacc.2013.05.072 |
0.321 |
|
| 2013 |
Ferreira J, Ezekowitz MD, Connolly SJ, Brueckmann M, Fraessdorf M, Reilly PA, Yusuf S, Wallentin L. Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial. European Journal of Heart Failure. 15: 1053-61. PMID 23843099 DOI: 10.1093/Eurjhf/Hft111 |
0.374 |
|
| 2013 |
Fathima FN, Joshi R, Agrawal T, Hegde S, Xavier D, Misquith D, Chidambaram N, Kalantri SP, Chow C, Islam S, Devereaux PJ, Gupta R, Pais P, Yusuf S. Rationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981). American Heart Journal. 166: 4-12. PMID 23816015 DOI: 10.1016/J.Ahj.2013.03.024 |
0.365 |
|
| 2013 |
Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, ... ... Yusuf S, et al. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation. 128: 237-43. PMID 23770747 DOI: 10.1161/Circulationaha.112.001139 |
0.322 |
|
| 2013 |
Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. Journal of the American College of Cardiology. 62: 900-8. PMID 23770182 DOI: 10.1016/J.Jacc.2013.05.042 |
0.33 |
|
| 2013 |
Hori M, Connolly SJ, Zhu J, Liu LS, Lau CP, Pais P, Xavier D, Kim SS, Omar R, Dans AL, Tan RS, Chen JH, Tanomsup S, Watanabe M, Koyanagi M, ... ... Yusuf S, et al. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke; a Journal of Cerebral Circulation. 44: 1891-6. PMID 23743976 DOI: 10.1161/Strokeaha.113.000990 |
0.335 |
|
| 2013 |
Mendis S, O'Brien E, Seedat YK, Yusuf S. Hypertension and diabetes: entry points for prevention and control of the global cardiovascular epidemic. International Journal of Hypertension. 2013: 878460. PMID 23653856 DOI: 10.1155/2013/878460 |
0.351 |
|
| 2013 |
Alhabib KF, Jolly SS, Yusuf S, Alsheikh-Ali AA, Al Suwaidi J, Hersi A, Sulaiman K, Al Saif S, Almahmeed W, Asaad N, Amin H, Al-Motarreb A, Alfaleh H, Alnemer K, Thalib L. Impact of access to hospitals with catheterization facilities in the second Gulf Registry of Acute Coronary Events (Gulf RACE-2). Coronary Artery Disease. 24: 412-8. PMID 23652362 DOI: 10.1097/Mca.0B013E328361A910 |
0.302 |
|
| 2013 |
Healey JS, Eikelboom J, Yang S, Themeles E, Connolly SJ, Yusuf S, Douketis J, Wallentin L, Oldgren J, Heidbuchel H, Avezum A, Reilly P, Ezekowitz M. Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Circulation. 127: e506. PMID 23646374 DOI: 10.1161/Circulationaha.112.154732 |
0.334 |
|
| 2013 |
Mente A, O'Donnell MJ, Yusuf S. Mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension. 61: e59. PMID 23589564 DOI: 10.1161/Hypertensionaha.113.01307 |
0.343 |
|
| 2013 |
Lonn EM, Bosch J, Diaz R, Lopez-Jaramillo P, Ramachandran A, Hâncu N, Hanefeld M, Krum H, Ryden L, Smith S, McQueen MJ, Dyal L, Yusuf S, Gerstein HC. Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE). Diabetes Care. 36: 2466-74. PMID 23564916 DOI: 10.2337/Dc12-2129 |
0.323 |
|
| 2013 |
Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, Lotan C. Oxygen therapy in acute coronary syndrome: are the benefits worth the risk? European Heart Journal. 34: 1630-5. PMID 23554440 DOI: 10.1093/Eurheartj/Eht110 |
0.304 |
|
| 2013 |
Smith R, McCready T, Yusuf S. Combination therapy to prevent cardiovascular disease: slow progress. Jama. 309: 1595-1596. PMID 23529576 DOI: 10.1001/Jama.2013.3180 |
0.41 |
|
| 2013 |
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, ... ... Yusuf S, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. The New England Journal of Medicine. 368: 1179-88. PMID 23477676 DOI: 10.1097/Sa.0000000000000033 |
0.33 |
|
| 2013 |
Hijazi Z, Oldgren J, Wallentin L, Andersson U, Connolly SJ, Yusuf S, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A. Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy". Circulation. 127: e278-9. PMID 23437443 DOI: 10.1161/Circulationaha.112.133546 |
0.402 |
|
| 2013 |
Lip GYH, Connolly S, Yusuf S, Shestakovska O, Flaker G, Hart R, Lanas F, Xavier D, Eikelboom J. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study. Circulation-Arrhythmia and Electrophysiology. 6: 31-38. PMID 23390125 DOI: 10.1161/Circep.112.975847 |
0.314 |
|
| 2013 |
Nieuwlaat R, Schwalm J, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease European Heart Journal. 34: 1262-1269. PMID 23376448 DOI: 10.1093/Eurheartj/Ehs481 |
0.329 |
|
| 2013 |
Mayosi BM, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, Jung H, Pandie S, Smieja M, Thabane L, Francis V, Thomas KM, Thomas B, Awotedu AA, Magula NP, ... ... Yusuf S, et al. Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis. American Heart Journal. 165: 109-15.e3. PMID 23351812 DOI: 10.1016/J.Ahj.2012.08.006 |
0.353 |
|
| 2013 |
Cheng X, Li W, Guo J, Wang Y, Gu H, Teo K, Liu L, Yusuf S. Physical activity levels, sport activities, and risk of acute myocardial infarction: results of the INTERHEART study in China. Angiology. 65: 113-21. PMID 23324448 DOI: 10.1177/0003319712470559 |
0.317 |
|
| 2013 |
Pogue JM, Devereaux P, Thorlund K, Yusuf S. Central statistical monitoring: Detecting fraud in clinical trials Clinical Trials. 10: 225-235. PMID 23283577 DOI: 10.1177/1740774512469312 |
0.328 |
|
| 2013 |
Dans AL, Connolly SJ, Wallentin L, Yang S, Nakamya J, Brueckmann M, Ezekowitz M, Oldgren J, Eikelboom JW, Reilly PA, Yusuf S. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 127: 634-40. PMID 23271794 DOI: 10.1161/Circulationaha.112.115386 |
0.348 |
|
| 2013 |
O'Donnell MJ, Mente A, Smyth A, Yusuf S. Salt intake and cardiovascular disease: why are the data inconsistent? European Heart Journal. 34: 1034-40. PMID 23257945 DOI: 10.1093/Eurheartj/Ehs409 |
0.362 |
|
| 2013 |
Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Rydén L, Sleight P, Teo KK, Yusuf S. Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial. Journal of Hypertension. 31: 414-21. PMID 23249829 DOI: 10.1097/Hjh.0B013E32835Bf7B0 |
0.341 |
|
| 2013 |
McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clinical Biochemistry. 46: 5-9. PMID 23063983 DOI: 10.1016/J.Clinbiochem.2012.10.003 |
0.38 |
|
| 2013 |
McDonald SD, Yusuf S, Walsh MW, Lonn E, Teo K, Anand SS, Pogue J, Islam S, Devereaux PJ, Gerstein HC. Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia. Diabetic Medicine : a Journal of the British Diabetic Association. 30: e1-7. PMID 23050859 DOI: 10.1111/Dme.12033 |
0.326 |
|
| 2013 |
Coppens M, Eikelboom JW, Hart RG, Yusuf S, Lip GYH, Dorian P, Shestakovska O, Connolly SJ. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy European Heart Journal. 34: 170-176. PMID 23018151 DOI: 10.1093/Eurheartj/Ehs314 |
0.346 |
|
| 2013 |
Khatib R, Joseph P, Briel M, Yusuf S, Healey J. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. International Journal of Cardiology. 165: 17-24. PMID 22421406 DOI: 10.1016/J.Ijcard.2012.02.009 |
0.382 |
|
| 2013 |
Guo J, Li W, Cheng XR, Wang Y, Gu HQ, Teo K, Liu LS, Yusuf S. Physical activity levels, sport activities and risk of acute myocardial infarction: results of the INTERHEART study in China European Heart Journal. 34: 5810. DOI: 10.1093/Eurheartj/Eht310.P5810 |
0.318 |
|
| 2013 |
Xavier D, Gupta R, Sigamani A, Kamath D, Xavier F, Girish P, Joshi R, Devereaux PJ, Pais P, Yusuf S. Community health worker based interventions in secondary prevention of CVD in India (SPREAD): methods and baseline results European Heart Journal. 34: 4313. DOI: 10.1093/Eurheartj/Eht309.P4313 |
0.359 |
|
| 2013 |
Lip G, Clemens A, Noack H, Ferreira J, Connolly S, Yusuf S. Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate European Heart Journal. 34: 4278. DOI: 10.1093/Eurheartj/Eht309.P4278 |
0.348 |
|
| 2013 |
Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger C, Mcmurray JJV, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction European Heart Journal. 34: 1480. DOI: 10.1093/Eurheartj/Eht308.P1480 |
0.321 |
|
| 2013 |
Maggioni AP, Fabbri G, Bosch J, Dyal L, Ryden LE, Gerstein HC, Yusuf S. Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction European Heart Journal. 34: 1966-1966. DOI: 10.1093/Eurheartj/Eht308.1966 |
0.318 |
|
| 2013 |
Joseph P, Pare G, Connolly S, Ezekowitz M, Wallentin L, Reilly P, Themeles E, Yusuf S. Effect Of Dabigatran On Serum Apolipoprotein B And Apolipoprotein A1 Concentrations Journal of the American College of Cardiology. 61. DOI: 10.1016/S0735-1097(13)60300-9 |
0.311 |
|
| 2012 |
Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation. 126: 2705-12. PMID 23212996 DOI: 10.1161/Circulationaha.112.103234 |
0.353 |
|
| 2012 |
Mehta SR, Jolly SS, Cairns J, Niemela K, Rao SV, Cheema AN, Steg PG, Cantor WJ, Džavík V, Budaj A, Rokoss M, Valentin V, Gao P, Yusuf S. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. Journal of the American College of Cardiology. 60: 2490-9. PMID 23103036 DOI: 10.1016/J.Jacc.2012.07.050 |
0.391 |
|
| 2012 |
Mancia G, Parati G, Bilo G, Gao P, Fagard R, Redon J, Czuriga I, Polák M, Ribeiro JM, Sanchez R, Trimarco B, Verdecchia P, van Mieghem W, Teo K, Sleight P, ... Yusuf S, et al. Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension. 60: 1400-6. PMID 23071122 DOI: 10.1161/Hypertensionaha.112.199562 |
0.301 |
|
| 2012 |
Flaker GC, Eikelboom JW, Shestakovska O, Connolly SJ, Kaatz S, Budaj A, Husted S, Yusuf S, Lip GYH, Hart RG. Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial Stroke. 43: 3291-3297. PMID 23033347 DOI: 10.1161/Strokeaha.112.664144 |
0.37 |
|
| 2012 |
Liang Y, Mente A, Yusuf S, Gao P, Sleight P, Zhu J, Fagard R, Lonn E, Teo KK. Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 184: E857-66. PMID 23027910 DOI: 10.1503/Cmaj.120412 |
0.312 |
|
| 2012 |
Van Spall HG, Wallentin L, Yusuf S, Eikelboom JW, Nieuwlaat R, Yang S, Kabali C, Reilly PA, Ezekowitz MD, Connolly SJ. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation. 126: 2309-16. PMID 23027801 DOI: 10.1161/Circulationaha.112.101808 |
0.312 |
|
| 2012 |
Hori M, Connolly SJ, Zhu J, Liu LS, Lau C, Pais P, Xavier D, Kim SS, Omar R, Dans AL, Tan RS, Chen J, Tanomsup S, Watanabe M, Koyanagi M, ... ... Yusuf S, et al. Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation : Analysis in Asian Population in RE-LY Trial Cerebrovascular Diseases. 34: 9-9. PMID 22965283 DOI: 10.1159/000341759 |
0.309 |
|
| 2012 |
Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. European Heart Journal. 33: 2804-12. PMID 22922507 DOI: 10.1093/Eurheartj/Ehs250 |
0.39 |
|
| 2012 |
Kappert K, Böhm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation. 126: 934-41. PMID 22829023 DOI: 10.1161/Circulationaha.111.086660 |
0.403 |
|
| 2012 |
Eikelboom JW, Connolly SJ, Gao P, Paolasso E, Caterina RD, Husted S, O’Donnell M, Yusuf S, Hart RG. Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease Journal of Stroke & Cerebrovascular Diseases. 21: 429-435. PMID 22818021 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.05.007 |
0.358 |
|
| 2012 |
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Heidbuchle H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation. 126: 343-8. PMID 22700854 DOI: 10.1161/Circulationaha.111.090464 |
0.348 |
|
| 2012 |
Gerstein HC, Bosch J, Dagenais GR, DÃaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. Basal insulin and cardiovascular and other outcomes in dysglycemia. The New England Journal of Medicine. 367: 319-28. PMID 22686416 DOI: 10.1056/Nejmoa1203858 |
0.326 |
|
| 2012 |
Bosch J, Gerstein HC, Dagenais GR, DÃaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. The New England Journal of Medicine. 367: 309-18. PMID 22686415 DOI: 10.1056/Nejmoa1203859 |
0.371 |
|
| 2012 |
Yusuf S, Cairns J. The perilous state of independent randomized clinical trials and related applied research in Canada Canadian Medical Association Journal. 184: 1997-2002. PMID 22619342 DOI: 10.1503/Cmaj.110598 |
0.314 |
|
| 2012 |
Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. Journal of the American College of Cardiology. 59: 1785-95. PMID 22575317 DOI: 10.1016/J.Jacc.2011.12.044 |
0.35 |
|
| 2012 |
O'Donnell M, Teo K, Gao P, Anderson C, Sleight P, Dans A, Marzona I, Bosch J, Probstfield J, Yusuf S. Cognitive impairment and risk of cardiovascular events and mortality. European Heart Journal. 33: 1777-86. PMID 22551598 DOI: 10.1093/Eurheartj/Ehs053 |
0.37 |
|
| 2012 |
Karthikeyan G, Zühlke L, Engel M, Rangarajan S, Yusuf S, Teo K, Mayosi BM. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. American Heart Journal. 163: 535-40.e1. PMID 22520517 DOI: 10.1016/J.Ahj.2012.01.003 |
0.353 |
|
| 2012 |
Verdecchia P, Dagenais G, Healey J, Gao P, Dans AL, Chazova I, Binbrek AS, Iacobellis G, Ferreira R, Holwerda N, Karatzas N, Keltai M, Mancia G, Sleight P, Teo K, ... Yusuf S, et al. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. Journal of Hypertension. 30: 1004-14. PMID 22495138 DOI: 10.1097/Hjh.0B013E3283522A51 |
0.413 |
|
| 2012 |
Hart RG, Diener H, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S. Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran The RE-LY Trial Stroke. 43: 1511-1517. PMID 22492518 DOI: 10.1161/Strokeaha.112.650614 |
0.342 |
|
| 2012 |
Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy Circulation. 125: 1605-1616. PMID 22374183 DOI: 10.1161/Circulationaha.111.038729 |
0.408 |
|
| 2012 |
Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, Yusuf S. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies Canadian Medical Association Journal. 184. PMID 22371515 DOI: 10.1503/Cmaj.111173 |
0.337 |
|
| 2012 |
Paré G, Ross S, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Fox KA, Eikelboom JW. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. Circulation. Cardiovascular Genetics. 5: 250-6. PMID 22368149 DOI: 10.1161/Circgenetics.111.961417 |
0.383 |
|
| 2012 |
Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, Saleheen D, Tanaka T, Anand SS, Chambers JC, Kleber ME, ... ... Yusuf S, et al. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. Plos Medicine. 9: e1001177. PMID 22363213 DOI: 10.1371/Journal.Pmed.1001177 |
0.317 |
|
| 2012 |
Flaker G, Ezekowitz M, Yusuf S, Wallentin L, Noack H, Brueckmann M, Reilly P, Hohnloser SH, Connolly S. Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation: Results From the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Study Journal of the American College of Cardiology. 59: 854-855. PMID 22361407 DOI: 10.1016/J.Jacc.2011.10.896 |
0.317 |
|
| 2012 |
Mente A, Yusuf S. Reducing cardiovascular mortality through lifestyle change in Japan. European Heart Journal. 33: 428-9. PMID 22334624 DOI: 10.1093/Eurheartj/Ehr446 |
0.303 |
|
| 2012 |
Diener HC, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GY, O'Donnell M, Hohnloser SH, Hankey GJ, Shestakovska O, Yusuf S. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. The Lancet. Neurology. 11: 225-31. PMID 22305462 DOI: 10.1016/S1474-4422(12)70017-0 |
0.35 |
|
| 2012 |
Hu B, Li W, Wang X, Liu L, Teo K, Yusuf S. Marital status, education, and risk of acute myocardial infarction in Mainland China: the INTER-HEART study. Journal of Epidemiology / Japan Epidemiological Association. 22: 123-9. PMID 22245707 DOI: 10.2188/Jea.Je20100175 |
0.341 |
|
| 2012 |
Held C, Iqbal R, Lear SA, Rosengren A, Islam S, Mathew J, Yusuf S. Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study. European Heart Journal. 33: 452-66. PMID 22238330 DOI: 10.1093/Eurheartj/Ehr432 |
0.333 |
|
| 2012 |
Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ. Myocardial Ischemic Events in Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin in the RE-LY Trial Circulation. 125: 669-76. PMID 22215856 DOI: 10.1161/Circulationaha.111.055970 |
0.389 |
|
| 2012 |
Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, Fagard R, Verdecchia P, Weber M, Böhm M, Williams B, Yusoff K, Teo K, Yusuf S. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). Journal of the American College of Cardiology. 59: 74-83. PMID 22192672 DOI: 10.1016/J.Jacc.2011.09.040 |
0.317 |
|
| 2012 |
Lamy A, Devereaux PJ, Prabhakaran D, Hu S, Piegas LS, Straka Z, Paolasso E, Taggart D, Lanas F, Akar AR, Jain A, Noiseux N, Ou Y, Chrolavicius S, Ng J, ... Yusuf S, et al. Rationale and design of the coronary artery bypass grafting surgery off or on pump revascularization study: a large international randomized trial in cardiac surgery. American Heart Journal. 163: 1-6. PMID 22172429 DOI: 10.1016/J.Ahj.2011.10.007 |
0.315 |
|
| 2012 |
Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia. 55: 36-45. PMID 22038523 DOI: 10.1007/S00125-011-2357-4 |
0.339 |
|
| 2012 |
Lamy A, Tong W, Gao P, Chrolavicius S, Gafni A, Yusuf S, Connolly SJ. The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trial. The Canadian Journal of Cardiology. 28: 95-101. PMID 21983111 DOI: 10.1016/J.Cjca.2011.08.112 |
0.356 |
|
| 2012 |
Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, Jung H, Desai D, Bosch J, Yusuf S, Gerstein HC, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. European Journal of Preventive Cardiology. 19: 755-64. PMID 21551215 DOI: 10.1177/1741826711409327 |
0.356 |
|
| 2012 |
Swahn E, Alfredsson J, Afzal R, Budaj A, Chrolavicius S, Fox K, Jolly S, Mehta SR, Winter Rd, Yusuf S. Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials European Heart Journal. 33: 51-60. PMID 19202154 DOI: 10.1093/Eurheartj/Ehp009 |
0.352 |
|
| 2012 |
Eikelboom JW, Connolly SJ, Healey JS, Yang S, Yusuf S, Wallentin L, Oldgren J, Ezekowitz M, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, et al. Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial” Circulation. 125. DOI: 10.1161/Circulationaha.111.061721 |
0.356 |
|
| 2012 |
Liesenfeld KH, Lehr T, Dansirikul C, Reilly PA, Connolly SJ, Ezekowitz MD, Yusuf S, Wallentin L, Haertter S, Staab A. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: reply to a rebuttal Journal of Thrombosis and Haemostasis. 10: 502-504. DOI: 10.1111/J.1538-7836.2011.04609.X |
0.314 |
|
| 2012 |
Coppens M, Eikelboom J, Hart R, Yusuf S, Lip G, Dorian P, Shestakovska O, Connolly S. The Cha2Ds2-Vasc Score Identifies Af Patients With A Chads2 Score Of 0 Or 1 Treated With Antiplatelet Therapy Who Are Unlikely To Benefit From Oral Anticoagulant Therapy Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)60571-3 |
0.323 |
|
| 2012 |
Nieuwlaat R, Haynes R, Duffy C, Reilly PA, Themeles E, Morillo CA, Yusuf S, Connolly SJ. 902 Cluster Randomized Controlled Trial to Test the Effect of Computer-Generated Individualized Audit and Feedback to Patients and Physicians on Clinical Outcomes in Atrial Fibrillation Patients Participating in a Large Multi-Center Trial of Dabigatran Canadian Journal of Cardiology. 28. DOI: 10.1016/J.Cjca.2012.07.742 |
0.327 |
|
| 2012 |
Lamy A, Devereaux P, Prabhakaran D, Taggart D, Hu S, Paolasso E, Straka Z, Piegas L, Akar R, Ou N, Chrolavicius S, Yusuf S. 901 Importance of Risk Stratification to Explain International Variations in Results of the Coronary Trial (Off-Pump Vs. On-Pump Cabg Surgery) — the Canadian Results Canadian Journal of Cardiology. 28: S416-S417. DOI: 10.1016/J.Cjca.2012.07.741 |
0.321 |
|
| 2011 |
Bordeleau L, Dagenais G, Yakubovich N, Yusuf S, Probstfield J, Riddle M, Ryden L, Xu L, Bosch J, Gerstein H. Incident cancers in people with dysglycemia and other cardiovascular risk factors: Cohort study of the ORIGIN trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1504. PMID 28023620 DOI: 10.1200/Jco.2011.29.15_Suppl.1504 |
0.325 |
|
| 2011 |
Ariti CA, Cleland JG, Pocock SJ, Pfeffer MA, Swedberg K, Granger CB, McMurray JJ, Michelson EL, Ostergren J, Yusuf S. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. American Heart Journal. 162: 900-6. PMID 22093207 DOI: 10.1016/J.Ahj.2011.08.003 |
0.348 |
|
| 2011 |
Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM. Level of systolic blood pressure within the normal range and risk of recurrent stroke Jama - Journal of the American Medical Association. 306: 2137-2144. PMID 22089721 DOI: 10.1001/Jama.2011.1650 |
0.345 |
|
| 2011 |
Oldgren J, Alings M, Darius H, Diener H, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ. Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial Annals of Internal Medicine. 155: 660-667. PMID 22084332 DOI: 10.7326/0003-4819-155-10-201111150-00004 |
0.356 |
|
| 2011 |
Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Ã, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, ... ... Yusuf S, et al. Dronedarone in high-risk permanent atrial fibrillation. The New England Journal of Medicine. 365: 2268-76. PMID 22082198 DOI: 10.1056/Nejmoa1109867 |
0.347 |
|
| 2011 |
Connolly SJ, Eikelboom JW, Ng J, Hirsh J, Yusuf S, Pogue J, de Caterina R, Hohnloser S, Hart RG. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Annals of Internal Medicine. 155: 579-86. PMID 22041946 DOI: 10.7326/0003-4819-155-9-201111010-00004 |
0.324 |
|
| 2011 |
Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, et al. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. Plos Medicine. 8: e1001106. PMID 22022235 DOI: 10.1371/Journal.Pmed.1001106 |
0.305 |
|
| 2011 |
Lamy A, Wang X, Gao P, Tong W, Gafni A, Dans A, Avezum A, Ferreira R, Young J, Yusuf S, Teo K. The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. Journal of Medical Economics. 14: 792-7. PMID 21981559 DOI: 10.3111/13696998.2011.627405 |
0.396 |
|
| 2011 |
Liesenfeld K, Lehr T, Dansirikul C, Reilly PA, Connolly SJ, Ezekowitz MD, Yusuf S, Wallentin L, Haertter S, Staab A. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. Journal of Thrombosis and Haemostasis. 9: 2168-2175. PMID 21972820 DOI: 10.1111/J.1538-7836.2011.04498.X |
0.334 |
|
| 2011 |
Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet (London, England). 378: 1231-43. PMID 21872920 DOI: 10.1016/S0140-6736(11)61215-4 |
0.336 |
|
| 2011 |
Barzilay JI, Gao P, Rydén L, Schumacher H, Probstfield J, Commerford P, Dans A, Ferreira R, Keltai M, Paolasso E, Yusuf S, Teo K. Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes The TRANSCEND study Diabetes Care. 34: 1902-1907. PMID 21788624 DOI: 10.2337/Dc11-0545 |
0.334 |
|
| 2011 |
Sun JC, Teoh KH, Sheth T, Landry D, Jung H, Warkentin TE, Yusuf S, Lamy A, Eikelboom JW. Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study. Journal of Thrombosis and Thrombolysis. 32: 378-85. PMID 21748448 DOI: 10.1007/S11239-011-0613-6 |
0.301 |
|
| 2011 |
Schmieder RE, Mann JFE, Schumacher H, Gao P, Mancia G, Weber MA, Mcqueen M, Koon T, Yusuf S. Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease Journal of the American Society of Nephrology. 22: 1353-1364. PMID 21719791 DOI: 10.1681/Asn.2010091001 |
0.386 |
|
| 2011 |
Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clinical Chemistry. 57: 1146-53. PMID 21700956 DOI: 10.1373/Clinchem.2011.164574 |
0.344 |
|
| 2011 |
Lamy A, Natarajan M, Yusuf S. Medical treatment, PCI, or CABG for coronary artery disease? Bmj (Clinical Research Ed.). 342: d966. PMID 21636638 DOI: 10.1136/Bmj.D966 |
0.338 |
|
| 2011 |
Su WS, Gangji AS, Margetts PM, Bosch J, Yusuf S, Clase CM, Ganame J, Noseworthy M, Lonn E, Jain AK, McCormick B, Brimble KS. The fluid study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients. Peritoneal Dialysis International : Journal of the International Society For Peritoneal Dialysis. 31: 529-36. PMID 21632446 DOI: 10.3747/Pdi.2010.00232 |
0.32 |
|
| 2011 |
Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, ... Yusuf S, et al. Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial Circulation. 123: 2363-2372. PMID 21576658 DOI: 10.1161/Circulationaha.110.004747 |
0.364 |
|
| 2011 |
Hamon M, Mehta S, Steg PG, Faxon D, Kerkar P, Rupprecht HJ, Tanguay JF, Afzal R, Yusuf S. Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 7: 91-7. PMID 21550908 DOI: 10.4244/Eijv7I1A16 |
0.372 |
|
| 2011 |
Holman RR, Zinman B, Yusuf S, Sheridan PM, Anand SS, Bosch JJ, Conget I, Davies MJ, Pirags V, Dagenais GR, Pogue JM, Zimmet PZ, Gerstein HC. Incidence of diabetes following ramipril or rosiglitazone withdrawal Diabetes Care. 34: 1265-1269. PMID 21515846 DOI: 10.2337/Dc10-1567 |
0.313 |
|
| 2011 |
Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, Leslie K, Rao-Melacini P, Chrolavicius S, Yang H, MacDonald C, Avezum A, Lanthier L, Hu W, Yusuf S. Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery: A Cohort Study Annals of Internal Medicine. 154: 523-528. PMID 21502650 DOI: 10.7326/0003-4819-154-8-201104190-00003 |
0.376 |
|
| 2011 |
Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 377: 1409-20. PMID 21470671 DOI: 10.1016/S0140-6736(11)60404-2 |
0.384 |
|
| 2011 |
Hori M, Connolly SJ, Ezekowitz MD, Reilly PA, Yusuf S, Wallentin L. Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial. Circulation. 75: 800-805. PMID 21436594 DOI: 10.1253/Circj.Cj-11-0191 |
0.327 |
|
| 2011 |
Verma S, Gupta M, Holmes DT, Xu L, Teoh H, Gupta S, Yusuf S, Lonn EM. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study. European Heart Journal. 32: 2135-42. PMID 21415069 DOI: 10.1093/Eurheartj/Ehr066 |
0.417 |
|
| 2011 |
Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ. Irbesartan in patients with atrial fibrillation. The New England Journal of Medicine. 364: 928-38. PMID 21388310 DOI: 10.1056/Nejmoa1008816 |
0.417 |
|
| 2011 |
Teo KK, Sleight P, Gao P, Yusuf S, Connolly S, Swedberg K, Pfeffer MA, Granger CB, McMurray JJV, Sjoelie AK, Massie BM, Carson P, Lewis JB, Wachtell K, Dahlof B, et al. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration Journal of Hypertension. 29: 623-635. PMID 21358417 DOI: 10.1097/Hjh.0B013E328344A7De |
0.345 |
|
| 2011 |
Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study. Annals of Internal Medicine. 154: 310-8. PMID 21357908 DOI: 10.7326/0003-4819-154-5-201103010-00005 |
0.383 |
|
| 2011 |
Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation. 123: 1098-107. PMID 21357827 DOI: 10.1161/Circulationaha.110.964171 |
0.389 |
|
| 2011 |
Thabane L, Wells G, Cook R, Platt R, Pogue J, Pullenayegum E, Matthews D, McCready T, Devereaux PJ, Cairns JA, Yusuf S. Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group. Trials. 12: 48. PMID 21332987 DOI: 10.1186/1745-6215-12-48 |
0.306 |
|
| 2011 |
Jolly SS, Niemelä K, Xavier D, Widimsky P, Budaj A, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Cairns J, Chrolavicius S, Yusuf S, Mehta SR. Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. American Heart Journal. 161: 254-260.e1-4. PMID 21315206 DOI: 10.1016/J.Ahj.2010.11.021 |
0.36 |
|
| 2011 |
Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, ... ... Yusuf S, et al. Apixaban in patients with atrial fibrillation. The New England Journal of Medicine. 364: 806-17. PMID 21309657 DOI: 10.1056/Nejmoa1007432 |
0.372 |
|
| 2011 |
Chow CK, Islam S, Bautista L, Rumboldt Z, Yusufali A, Xie C, Anand SS, Engert JC, Rangarajan S, Yusuf S. Parental history and myocardial infarction risk across the world: the INTERHEART Study. Journal of the American College of Cardiology. 57: 619-27. PMID 21272754 DOI: 10.1016/J.Jacc.2010.07.054 |
0.307 |
|
| 2011 |
Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 123: 131-6. PMID 21200007 DOI: 10.1161/Circulationaha.110.977546 |
0.302 |
|
| 2011 |
McGorrian C, Yusuf S, Islam S, Jung H, Rangarajan S, Avezum A, Prabhakaran D, Almahmeed W, Rumboldt Z, Budaj A, Dans AL, Gerstein HC, Teo K, Anand SS. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. European Heart Journal. 32: 581-9. PMID 21177699 DOI: 10.1093/Eurheartj/Ehq448 |
0.353 |
|
| 2011 |
Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, ... Yusuf S, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies Lancet Neurology. 10: 43-53. PMID 20980201 DOI: 10.1016/S1474-4422(10)70250-7 |
0.317 |
|
| 2011 |
Nicolson WB, Steadman CD, Brown P, Jeilan M, Yusuf S, Kundu S, Sandilands AJ, Stafford PJ, Schlindwein FS, McCann GP, Ng GA. 159 Pilot Study exploring the regional repolarisation instability index in relation to myocardial heterogeneity and prediction of ventricular arrhythmia and death Heart. 97. DOI: 10.1136/Heartjnl-2011-300198.159 |
0.354 |
|
| 2011 |
Aulin JK, Ezekowitz MD, Andersson U, Connolly SJ, Huber K, Reilly PA, Siegbahn A, Wallentin L, Yusuf S, Oldgren J. Interleukin-6 And C-Reactive Protein And Risk For Death And Cardiovascular Events In Patients With Atrial Fibrillation Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)60091-0 |
0.337 |
|
| 2011 |
Oldgren J, Ezekowitz MD, Alings M, Diener H, Reilly PA, Yusuf S, Wallentin L, Connolly S. Dabigatran Versus Warfarin And Impact Of Chad2-Vasc Score On Outcome In Atrial Fibrillation Patients: A Re-Ly Subgroup Analysis Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)60007-7 |
0.305 |
|
| 2011 |
Dagenais GR, Gao P, Teo KK, Proulx G, St-Hilaire R, Redon J, Sleight P, Yusuf S. 679 Predictive value of increased body weight and abdominal adiposity for cardiovascular events in high-risk patients a sub-study of the ontarget/transcend trials Canadian Journal of Cardiology. 27. DOI: 10.1016/J.Cjca.2011.07.565 |
0.336 |
|
| 2010 |
Dans AL, Teo K, Gao P, Chen J, Jae-Hyung K, Yusoff K, Chaithiraphan S, Zhu J, Lisheng L, Yusuf S. In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events. Plos One. 5. PMID 21200437 DOI: 10.1371/Journal.Pone.0013694 |
0.424 |
|
| 2010 |
Sun JC, Teoh KH, Lamy A, Sheth T, Ellins ML, Jung H, Yusuf S, Anand S, Connolly S, Whitlock RP, Eikelboom JW. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. American Heart Journal. 160: 1178-84. PMID 21146675 DOI: 10.1016/J.Ahj.2010.07.035 |
0.342 |
|
| 2010 |
van Rees Vellinga TE, Peters RJ, Yusuf S, Afzal R, Chrolavicius S, O'Donnell M, Mehta SR, Pluta W, Sacha J, Eikelboom JW. Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. American Heart Journal. 160: 1049-55. PMID 21146657 DOI: 10.1016/J.Ahj.2010.08.038 |
0.383 |
|
| 2010 |
Steg PG, Mehta S, Jolly S, Xavier D, Rupprecht H, Lopez-Sendon JL, Chrolavicius S, Rao SV, Granger CB, Pogue J, Laing S, Yusuf S. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux American Heart Journal. 160: 1029-1034. PMID 21146654 DOI: 10.1016/J.Ahj.2010.07.037 |
0.37 |
|
| 2010 |
Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation. 122: 2078-88. PMID 21098469 DOI: 10.1161/Circulationaha.109.873232 |
0.356 |
|
| 2010 |
Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S, Xavier D, Pasquale GD, Yusuf S. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial Lancet Neurology. 9: 1157-1163. PMID 21059484 DOI: 10.1016/S1474-4422(10)70274-X |
0.35 |
|
| 2010 |
Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KA, Eikelboom JW. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. The New England Journal of Medicine. 363: 1704-14. PMID 20979470 DOI: 10.1056/Nejmoa1008410 |
0.335 |
|
| 2010 |
Boyko EJ, Gerstein HC, Mohan V, Yusuf S, Sheridan P, Anand S, Shaw JE. Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic Medicine : a Journal of the British Diabetic Association. 27: 1226-32. PMID 20950379 DOI: 10.1111/J.1464-5491.2010.03064.X |
0.324 |
|
| 2010 |
Cairns JA, Yusuf S, Cook RJ, Cox J, Dagenais GR, Devereaux PJ, McAlister FA, McCready T. Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. The Canadian Journal of Cardiology. 26: 353-8. PMID 20847960 DOI: 10.1016/S0828-282X(10)70408-6 |
0.305 |
|
| 2010 |
Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine. 363: 930-42. PMID 20818903 DOI: 10.1056/Nejmoa0909475 |
0.323 |
|
| 2010 |
Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, ... ... Yusuf S, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet (London, England). 376: 1233-43. PMID 20817281 DOI: 10.1016/S0140-6736(10)61088-4 |
0.31 |
|
| 2010 |
Steg PG, Jolly SS, Mehta SR, Afzal R, Xavier D, Rupprecht HJ, López-Sendón JL, Budaj A, Diaz R, Avezum A, Widimsky P, Rao SV, Chrolavicius S, Meeks B, ... ... Yusuf S, et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. Jama. 304: 1339-49. PMID 20805623 DOI: 10.1001/Jama.2010.1320 |
0.348 |
|
| 2010 |
Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial The Lancet. 376: 975-983. PMID 20801496 DOI: 10.1016/S0140-6736(10)61194-4 |
0.347 |
|
| 2010 |
Jong P, McKelvie R, Yusuf S. Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction Bmj. 341: 376-378. PMID 20739364 DOI: 10.1136/Bmj.C4202 |
0.378 |
|
| 2010 |
Gerstein HC, Islam S, Anand S, Almahmeed W, Damasceno A, Dans A, Lang CC, Luna MA, McQueen M, Rangarajan S, Rosengren A, Wang X, Yusuf S. Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study. Diabetologia. 53: 2509-17. PMID 20711717 DOI: 10.1007/S00125-010-1871-0 |
0.355 |
|
| 2010 |
Caterina RD, Connolly SJ, Pogue J, Chrolavicius S, Budaj A, Morais J, Renda G, Yusuf S. Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W. European Heart Journal. 31: 2133-2140. PMID 20685676 DOI: 10.1093/Eurheartj/Ehq250 |
0.351 |
|
| 2010 |
Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease European Heart Journal. 31: 2092-2096. PMID 20675658 DOI: 10.1093/Eurheartj/Ehq242 |
0.313 |
|
| 2010 |
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S. Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. Diabetes Care. 33: 2250-3. PMID 20628086 DOI: 10.2337/Dc10-0452 |
0.307 |
|
| 2010 |
Yusuf S, Anand S. Deciphering the Causes of Cardiovascular and Other Complex Diseases in Populations: Achievements, Challenges, Opportunities, and Approaches Progress in Cardiovascular Diseases. 53: 62-67. PMID 20620428 DOI: 10.1016/J.Pcad.2010.02.001 |
0.329 |
|
| 2010 |
Gerstein HC, Yusuf S. Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: implications for the evaluation of antidiabetic drugs. American Heart Journal. 160: 1-2. PMID 20598964 DOI: 10.1016/J.Ahj.2010.05.019 |
0.311 |
|
| 2010 |
O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, ... ... Yusuf S, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 376: 112-23. PMID 20561675 DOI: 10.1016/S0140-6736(10)60834-3 |
0.324 |
|
| 2010 |
Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. Journal of the American College of Cardiology. 55: 2390-8. PMID 20488312 DOI: 10.1016/J.Jacc.2009.12.053 |
0.327 |
|
| 2010 |
Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 12: 738-45. PMID 20418272 DOI: 10.1093/Eurjhf/Hfq065 |
0.348 |
|
| 2010 |
O'Donnell M, Xavier D, Diener C, Sacco R, Lisheng L, Zhang H, Pias P, Truelsen T, Chin SL, Rangarajan S, Devilliers L, Damasceno A, Mondo C, Lanas F, Avezum A, ... ... Yusuf S, et al. Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke. Neuroepidemiology. 35: 36-44. PMID 20389123 DOI: 10.1159/000306058 |
0.317 |
|
| 2010 |
Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggioni AP, McMurray JJ. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. European Journal of Heart Failure. 12: 557-65. PMID 20356870 DOI: 10.1093/Eurjhf/Hfq040 |
0.345 |
|
| 2010 |
Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, Anand IS, Hart R, Connolly SJ. Cognitive function and anticoagulation control in patients with atrial fibrillation Circulation: Cardiovascular Quality and Outcomes. 3: 277-283. PMID 20233976 DOI: 10.1161/Circoutcomes.109.884171 |
0.358 |
|
| 2010 |
Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 121: 1439-46. PMID 20231536 DOI: 10.1161/Circulationaha.109.864199 |
0.408 |
|
| 2010 |
Yusuf S. Unresolved Issues in the Management of Hypertension Hypertension. 55: 832-834. PMID 20215564 DOI: 10.1161/Hypertensionaha.109.142349 |
0.391 |
|
| 2010 |
Eikelboom JW, O'Donnell M, Yusuf S, Diaz R, Flaker G, Hart R, Hohnloser S, Joyner C, Lawrence J, Pais P, Pogue J, Synhorst D, Connolly SJ. Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. American Heart Journal. 159: 348-353.e1. PMID 20211294 DOI: 10.1016/J.Ahj.2009.08.026 |
0.355 |
|
| 2010 |
Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. European Heart Journal. 31: 642-648. PMID 20176800 DOI: 10.1093/Eurheartj/Ehq030 |
0.361 |
|
| 2010 |
Jolly SS, Yusuf S. Which antithrombotic to use during PCI European Heart Journal. 31: 522-524. PMID 20150323 DOI: 10.1093/Eurheartj/Ehp563 |
0.378 |
|
| 2010 |
Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 121: 750-8. PMID 20124123 DOI: 10.1161/Circulationaha.109.891523 |
0.364 |
|
| 2010 |
Anderson JA, Hirsh J, Yusuf S, Johnston M, Afzal R, Mehta SR, Fox KA, Budaj A, Eikelboom JW. Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial. Journal of Thrombosis and Haemostasis : Jth. 8: 243-9. PMID 19943881 DOI: 10.1111/J.1538-7836.2009.03705.X |
0.352 |
|
| 2010 |
Bassand JP, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, Fox KA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. 31: 50-8. PMID 19825809 DOI: 10.1093/Eurheartj/Ehp401 |
0.384 |
|
| 2010 |
Morrison KM, Dyal L, Conner W, Helden E, Newkirk L, Yusuf S, Lonn E. Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth. Atherosclerosis. 208: 501-5. PMID 19699477 DOI: 10.1016/J.Atherosclerosis.2009.07.034 |
0.316 |
|
| 2010 |
Goyal A, Mehta SR, Gerstein HC, Afzal R, Yusuf S, Díaz R, Xavier D, Pais P, Liu L. Response to Letter Regarding Article, “Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction” Circulation. 122. DOI: 10.1161/Circulationaha.110.951830 |
0.351 |
|
| 2010 |
Oldgren J, Alings M, Darius H, Eikelboom J, Ezekowitz M, Parekh A, Pogue J, Reilly P, Yusuf S, Wallentin L, Connolly S. Dabigatran Versus Warfarin In Atrial Fibrillation Patients With Low, Moderate And High Chads2 Score: A Re-Ly Subgroup Analysis Journal of the American College of Cardiology. 55. DOI: 10.1016/S0735-1097(10)60003-4 |
0.301 |
|
| 2009 |
Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S. Iatrogenic adverse events in the coronary care unit. Circulation. Cardiovascular Quality and Outcomes. 2: 437-42. PMID 20031874 DOI: 10.1161/Circoutcomes.108.846493 |
0.335 |
|
| 2009 |
Anand SS, Xie C, Paré G, Montpetit A, Rangarajan S, McQueen MJ, Cordell HJ, Keavney B, Yusuf S, Hudson TJ, Engert JC. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study. Circulation. Cardiovascular Genetics. 2: 16-25. PMID 20031563 DOI: 10.1161/Circgenetics.108.813709 |
0.314 |
|
| 2009 |
Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, et al. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). The American Journal of Cardiology. 104: 1484-9. PMID 19932779 DOI: 10.1016/J.Amjcard.2009.07.018 |
0.388 |
|
| 2009 |
Lonn E, Yusuf S. Polypill: the evidence and the promise. Current Opinion in Lipidology. 20: 453-9. PMID 19884824 DOI: 10.1097/Mol.0B013E32833305A3 |
0.394 |
|
| 2009 |
Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJ, Yusuf S, Pfeffer MA, Swedberg K. Adherence to medication according to sex and age in the CHARM programme. European Journal of Heart Failure. 11: 1092-8. PMID 19875409 DOI: 10.1093/Eurjhf/Hfp142 |
0.338 |
|
| 2009 |
Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. Journal of the American College of Cardiology. 54: 1599-606. PMID 19833258 DOI: 10.1016/J.Jacc.2009.06.028 |
0.357 |
|
| 2009 |
Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 40: 3541-6. PMID 19797187 DOI: 10.1161/Strokeaha.109.555623 |
0.314 |
|
| 2009 |
Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S, et al. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. Circulation. 120: 1380-9. PMID 19770395 DOI: 10.1161/Circulationaha.109.865774 |
0.395 |
|
| 2009 |
Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 374: 543-50. PMID 19683640 DOI: 10.1016/S0140-6736(09)61378-7 |
0.394 |
|
| 2009 |
Jolly SS, Faxon DP, Fox KA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner CD, Chrolavicius S, Yusuf S, Mehta SR. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. Journal of the American College of Cardiology. 54: 468-76. PMID 19628124 DOI: 10.1016/J.Jacc.2009.03.062 |
0.307 |
|
| 2009 |
McMurray JJV, Granger CB, Östergren J, Yusuf S, Pfeffer MA, Swedberg K. Dual renin-angiotensin system blockade in heart failure. Journal of the American College of Cardiology. 54: 278. PMID 19589444 DOI: 10.1016/J.Jacc.2009.02.073 |
0.319 |
|
| 2009 |
Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. American Heart Journal. 158: 1-7.e1. PMID 19540385 DOI: 10.1016/J.Ahj.2009.04.019 |
0.313 |
|
| 2009 |
Pogue J, Walter SD, Yusuf S. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs. Clinical Trials. 6: 239-251. PMID 19528133 DOI: 10.1177/1740774509105223 |
0.315 |
|
| 2009 |
Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Böhm M, Williams B, Pogue J, Koon T, Yusuf S. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. Journal of Hypertension. 27: 1360-9. PMID 19506526 DOI: 10.1097/Hjh.0B013E32832D7370 |
0.38 |
|
| 2009 |
Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart (British Cardiac Society). 95: 1857-64. PMID 19482846 DOI: 10.1136/Hrt.2008.155796 |
0.363 |
|
| 2009 |
Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). Journal of the American College of Cardiology. 53: 2028-35. PMID 19477351 DOI: 10.1016/J.Jacc.2008.12.072 |
0.342 |
|
| 2009 |
Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, ... ... Yusuf S, et al. Early versus delayed invasive intervention in acute coronary syndromes. The New England Journal of Medicine. 360: 2165-75. PMID 19458363 DOI: 10.1056/Nejmoa0807986 |
0.327 |
|
| 2009 |
Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, ... ... Yusuf S, et al. Effect of telmisartan on renal outcomes: a randomized trial. Annals of Internal Medicine. 151: 1-10, W1-2. PMID 19451556 DOI: 10.7326/0003-4819-151-1-200907070-00122 |
0.36 |
|
| 2009 |
Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review European Journal of Preventive Cardiology. 16: 268-280. PMID 19398913 DOI: 10.1097/Hjr.0B013E328322Ca1B |
0.312 |
|
| 2009 |
Ezekowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. American Heart Journal. 157: 805-10, 810.e1-2. PMID 19376304 DOI: 10.1016/J.Ahj.2009.02.005 |
0.378 |
|
| 2009 |
Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, et al. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 98: 421-33. PMID 19347385 DOI: 10.1007/S00392-009-0014-4 |
0.365 |
|
| 2009 |
Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (London, England). 373: 1341-51. PMID 19339045 DOI: 10.1016/S0140-6736(09)60611-5 |
0.348 |
|
| 2009 |
Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. The New England Journal of Medicine. 360: 2066-78. PMID 19336502 DOI: 10.1056/Nejmoa0901301 |
0.395 |
|
| 2009 |
Goyal A, Mehta SR, Gerstein HC, DÃaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi KA, Zubaid M, Piegas LS, Widimsky P, Budaj A, Avezum A, ... Yusuf S, et al. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. American Heart Journal. 157: 763-70. PMID 19332208 DOI: 10.1016/J.Ahj.2008.12.007 |
0.324 |
|
| 2009 |
White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. Therapeutic Advances in Cardiovascular Disease. 3: 113-21. PMID 19299427 DOI: 10.1177/1753944708103658 |
0.316 |
|
| 2009 |
Joyner CD, Peters RJ, Afzal R, Chrolavicius S, Mehta SR, Fox KA, Granger CB, Franzosi MG, Flather M, Budaj A, Bassand JP, Yusuf S. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. American Heart Journal. 157: 502-8. PMID 19249421 DOI: 10.1016/J.Ahj.2008.10.028 |
0.394 |
|
| 2009 |
O'Donnell M, Yusuf S. Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurology. 8: 306-307. PMID 19233731 DOI: 10.1016/S1474-4422(09)70024-9 |
0.325 |
|
| 2009 |
Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 32: 915-20. PMID 19196892 DOI: 10.2337/Dc08-1709 |
0.354 |
|
| 2009 |
Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. European Journal of Heart Failure. 11: 170-7. PMID 19168515 DOI: 10.1093/Eurjhf/Hfn031 |
0.333 |
|
| 2009 |
Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes Research and Clinical Practice. 83: 387-93. PMID 19157618 DOI: 10.1016/J.Diabres.2008.12.005 |
0.344 |
|
| 2009 |
Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. Journal of the American College of Cardiology. 53: 244-53. PMID 19147041 DOI: 10.1016/J.Jacc.2008.09.041 |
0.316 |
|
| 2009 |
Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. American Heart Journal. 157: 132-40. PMID 19081409 DOI: 10.1016/J.Ahj.2008.08.023 |
0.372 |
|
| 2009 |
Abrahamsson P, Dobson J, Granger CB, McMurray JJ, Michelson EL, Pfeffer M, Pocock S, Solomon SD, Yusuf S, Swedberg K. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. European Heart Journal. 30: 338-45. PMID 19001475 DOI: 10.1093/Eurheartj/Ehn503 |
0.345 |
|
| 2009 |
Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, Fox KA, Wallentin L, Peters RJ, Granger CB, Joyner CD, Yusuf S. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. European Heart Journal. 30: 655-61. PMID 18713759 DOI: 10.1093/Eurheartj/Ehn358 |
0.402 |
|
| 2009 |
Sleight P, Yusuf S, Peto R, Rossi P, Ramsdale D, Bennett D, Bray C, Furse L. Early intravenous atenolol treatment in suspected acute myocardial infarction. Acta Medica Scandinavica. 651: 185-192. PMID 7034474 DOI: 10.1111/J.0954-6820.1981.Tb03655.X |
0.359 |
|
| 2009 |
Yusuf S, Pogue J, Teo K, Anderson C, Sleight P. Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply The Lancet. 373: 459. DOI: 10.1016/S0140-6736(09)60164-1 |
0.315 |
|
| 2008 |
McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. American Heart Journal. 156: 918-930. PMID 19061708 DOI: 10.1016/J.Ahj.2008.06.042 |
0.347 |
|
| 2008 |
Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. Journal of the American College of Cardiology. 52: 2000-7. PMID 19055992 DOI: 10.1016/J.Jacc.2008.09.011 |
0.387 |
|
| 2008 |
Mehta SR, Bassand J, Chrolavicius S, Diaz R, Fox KAA, Granger CB, Jolly S, Rupprecht H, Widimsky P, Yusuf S. Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy American Heart Journal. 156: 1080-1088. PMID 19033002 DOI: 10.1016/J.Ahj.2008.07.026 |
0.323 |
|
| 2008 |
Cohen-Solal A, McMurray JJ, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme. European Heart Journal. 29: 3022-8. PMID 18987098 DOI: 10.1093/Eurheartj/Ehn476 |
0.342 |
|
| 2008 |
Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S. Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range Circulation. 118: 2029-2037. PMID 18955670 DOI: 10.1161/Circulationaha.107.750000 |
0.359 |
|
| 2008 |
Mehta SR, Boden WE, Eikelboom JW, Flather M, Steg PG, Avezum A, Afzal R, Piegas LS, Faxon DP, Widimsky P, Budaj A, Chrolavicius S, Rupprecht H, Jolly S, Granger CB, ... ... Yusuf S, et al. Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes An Individual Patient–Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials Circulation. 118: 2038-2046. PMID 18955665 DOI: 10.1161/Circulationaha.108.789479 |
0.365 |
|
| 2008 |
Held C, Sumner G, Sheridan P, McQueen M, Smith S, Dagenais G, Yusuf S, Lonn E. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART). Vascular Medicine (London, England). 13: 245-53. PMID 18940900 DOI: 10.1177/1358863X08092102 |
0.318 |
|
| 2008 |
Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, Yusuf S. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 118: 1929-37. PMID 18936332 DOI: 10.1161/Circulationaha.107.738716 |
0.357 |
|
| 2008 |
Jolly SS, Pogue J, Haladyn K, Peters RJG, Fox KAA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study European Heart Journal. 30: 900-907. PMID 18819961 DOI: 10.1093/Eurheartj/Ehn417 |
0.325 |
|
| 2008 |
Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European Heart Journal. 29: 2641-50. PMID 18819960 DOI: 10.1093/Eurheartj/Ehn420 |
0.359 |
|
| 2008 |
Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet (London, England). 372: 1174-83. PMID 18757085 DOI: 10.1016/S0140-6736(08)61242-8 |
0.348 |
|
| 2008 |
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. The New England Journal of Medicine. 359: 1225-37. PMID 18753639 DOI: 10.1056/Nejmoa0804593 |
0.311 |
|
| 2008 |
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, ... ... Yusuf S, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (London, England). 372: 547-53. PMID 18707986 DOI: 10.1016/S0140-6736(08)61236-2 |
0.335 |
|
| 2008 |
Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Archives of Internal Medicine. 168: 1699-704. PMID 18695086 DOI: 10.1001/Archinte.168.15.1699 |
0.381 |
|
| 2008 |
McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 372: 224-33. PMID 18640459 DOI: 10.1016/S0140-6736(08)61076-4 |
0.344 |
|
| 2008 |
Marin-Neto JA, Rassi A, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT) American Heart Journal. 156: 37-43. PMID 18585495 DOI: 10.1016/J.Ahj.2008.04.001 |
0.421 |
|
| 2008 |
Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection Clinical Research in Cardiology. 97: 418-431. PMID 18454336 DOI: 10.1007/S00392-008-0668-3 |
0.395 |
|
| 2008 |
Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, Haridas KK, Jaison TM, Naik S, Maity AK, Yusuf S, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (London, England). 371: 1435-42. PMID 18440425 DOI: 10.1016/S0140-6736(08)60623-6 |
0.366 |
|
| 2008 |
MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal. 29: 1377-85. PMID 18413309 DOI: 10.1093/Eurheartj/Ehn153 |
0.381 |
|
| 2008 |
Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, Caterina RD, Flaker G, Yusuf S, Connolly SJ. Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk : The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W) Stroke. 39: 1482-1486. PMID 18323500 DOI: 10.1161/Strokeaha.107.500199 |
0.367 |
|
| 2008 |
Peters RJ, Joyner C, Bassand JP, Afzal R, Chrolavicius S, Mehta SR, Oldgren J, Wallentin L, Budaj A, Fox KA, Yusuf S. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. European Heart Journal. 29: 324-31. PMID 18245119 DOI: 10.1093/Eurheartj/Ehm616 |
0.391 |
|
| 2008 |
Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. European Journal of Heart Failure. 10: 157-63. PMID 18242128 DOI: 10.1016/J.Ejheart.2007.12.006 |
0.327 |
|
| 2008 |
Oldgren J, Wallentin L, Afzal R, Bassand J, Budaj A, Chrolavicius S, Fox KAA, Granger CB, Mehta SR, Pais P, Peters RJG, Xavier D, Zhu J, Yusuf S. Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment European Heart Journal. 29: 315-323. PMID 18084015 DOI: 10.1093/Eurheartj/Ehm578 |
0.385 |
|
| 2008 |
Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India Heart. 94: 16-26. PMID 18083949 DOI: 10.1136/Hrt.2007.132951 |
0.372 |
|
| 2008 |
Mann JF, Sheridan P, McQueen MJ, Held C, Arnold JM, Fodor G, Yusuf S, Lonn EM. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 23: 645-53. PMID 18003666 DOI: 10.1093/Ndt/Gfm485 |
0.383 |
|
| 2008 |
Solomon SD, Pfeffer MA, Pocock S, Marro J, McMurray JJV, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson E. Response to Letter Regarding Article, “Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure” Circulation. 118. DOI: 10.1161/Circulationaha.107.759662 |
0.339 |
|
| 2008 |
Connolly SJ, Eikelboom J, O’Donnell M, Pogue J, Yusuf S. Response to Letter Regarding Article, “Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation” Circulation. 117. DOI: 10.1161/Circulationaha.107.742353 |
0.351 |
|
| 2007 |
Hilbrich L, Truelsen T, Yusuf S. Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development International Journal of Stroke. 2: 104-108. PMID 18705961 DOI: 10.1111/J.1747-4949.2007.00118.X |
0.322 |
|
| 2007 |
Díaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. Jama. 298: 2399-405. PMID 18042917 DOI: 10.1001/Jama.298.20.2399 |
0.375 |
|
| 2007 |
Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, Investigators AW. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Journal of the American College of Cardiology. 50: 2156-2161. PMID 18036454 DOI: 10.1016/J.Jacc.2007.07.076 |
0.382 |
|
| 2007 |
Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. Journal of the American College of Cardiology. 50: 1959-66. PMID 17996561 DOI: 10.1016/J.Jacc.2007.07.067 |
0.333 |
|
| 2007 |
Mehta SR, Granger CB, Eikelboom JW, Bassand J, Wallentin L, Faxon DP, Peters RJG, Budaj A, Afzal R, Chrolavicius S, Fox KAA, Yusuf S. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. Journal of the American College of Cardiology. 50: 1742-1751. PMID 17964037 DOI: 10.1016/J.Jacc.2007.07.042 |
0.381 |
|
| 2007 |
Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy American Heart Journal. 154: 743-750. PMID 17893003 DOI: 10.1016/J.Ahj.2007.06.020 |
0.354 |
|
| 2007 |
Sanderson JE, Mayosi B, Yusuf S, Reddy S, Hu S, Chen Z, Timmis A. Global burden of cardiovascular disease. Heart (British Cardiac Society). 93: 1175. PMID 17890692 DOI: 10.1136/Hrt.2007.131060 |
0.364 |
|
| 2007 |
Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS, Valentin V, Moccetti T, Chrolavicius S, Afzal R, Yusuf S. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Annals of Internal Medicine. 147: 304-10. PMID 17785485 DOI: 10.7326/0003-4819-147-5-200709040-00005 |
0.307 |
|
| 2007 |
Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 116: 1482-7. PMID 17724259 DOI: 10.1161/Circulationaha.107.696906 |
0.372 |
|
| 2007 |
Salehian O, Healey J, Stambler B, Alnemer K, Almerri K, Grover J, Bata I, Mann J, Matthew J, Pogue J, Yusuf S, Dagenais G, Lonn E. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study. American Heart Journal. 154: 448-53. PMID 17719288 DOI: 10.1016/J.Ahj.2007.04.062 |
0.411 |
|
| 2007 |
Connolly SJ, Eikelboom J, O’Donnell M, Pogue J, Yusuf S. Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation Circulation. 116: 449-455. PMID 17646595 DOI: 10.1161/Circulationaha.107.695163 |
0.376 |
|
| 2007 |
Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 116: 627-36. PMID 17638930 DOI: 10.1161/Circulationaha.106.679779 |
0.355 |
|
| 2007 |
Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. The New England Journal of Medicine. 357: 217-27. PMID 17634457 DOI: 10.1056/Nejmoa065959 |
0.394 |
|
| 2007 |
Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. Journal of the American College of Cardiology. 50: 40-7. PMID 17601544 DOI: 10.1016/J.Jacc.2007.02.067 |
0.368 |
|
| 2007 |
Böhm M, Baumhäkel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, Koon T. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) American Heart Journal. 154: 94-101. PMID 17584560 DOI: 10.1016/J.Ahj.2007.03.024 |
0.395 |
|
| 2007 |
Peters RJG, Mehta S, Yusuf S. Acute coronary syndromes without ST segment elevation. Bmj. 334: 1265-1269. PMID 17569934 DOI: 10.1136/Bmj.39220.618646.Ae |
0.305 |
|
| 2007 |
O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Piña IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 115: 3111-20. PMID 17562950 DOI: 10.1161/Circulationaha.106.673442 |
0.349 |
|
| 2007 |
Keltai M, Tonelli M, Mann JFE, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. European Journal of Preventive Cardiology. 14: 312-318. PMID 17446813 DOI: 10.1097/01.Hjr.0000220582.19516.A6 |
0.378 |
|
| 2007 |
Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients. European Heart Journal. 28: 1382-8. PMID 17395677 DOI: 10.1093/Eurheartj/Ehm017 |
0.417 |
|
| 2007 |
Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 115: 1067-74. PMID 17339564 DOI: 10.1161/Circulationaha.106.633552 |
0.337 |
|
| 2007 |
Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation. 115: 1371-5. PMID 17339550 DOI: 10.1161/Circulationaha.106.661405 |
0.403 |
|
| 2007 |
Diener HC, Sacco RL, Yusuf S. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: The Prevention Regimen for Effectively Avoiding Second Strokes trial (PRoFESS) Cerebrovascular Diseases. 23: 368-380. PMID 17337887 DOI: 10.1159/000100105 |
0.321 |
|
| 2007 |
Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. European Journal of Heart Failure. 9: 510-7. PMID 17317308 DOI: 10.1016/J.Ejheart.2006.11.006 |
0.359 |
|
| 2007 |
Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. Jama. 297: 286-94. PMID 17227980 DOI: 10.1001/Jama.297.3.286 |
0.339 |
|
| 2007 |
Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure. 9: 83-91. PMID 17188020 DOI: 10.1016/J.Ejheart.2006.10.012 |
0.307 |
|
| 2007 |
Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (British Cardiac Society). 93: 59-64. PMID 16952975 DOI: 10.1136/Hrt.2005.083949 |
0.345 |
|
| 2007 |
Sandoval C, Walter SD, Krueger P, Smieja M, Smith A, Yusuf S, Loeb MB. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure Epidemiology and Infection. 135: 574-582. PMID 16938140 DOI: 10.1017/S095026880600714X |
0.303 |
|
| 2007 |
Blankenberg S, Yusuf S. Response to Letter Regarding Article, “The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?” Circulation. 115. DOI: 10.1161/Circulationaha.106.684464 |
0.317 |
|
| 2007 |
Yusuf S. Risk Factors for Early Myocardial Infarction in South Asians—Reply Jama. 297: 1880-1881. DOI: 10.1001/Jama.297.17.1881-A |
0.323 |
|
| 2006 |
Yusuf S, Bosch J. Independent design and conduct of clinical trials. Clinical Trials. 3: 503-507. PMID 17170033 DOI: 10.1177/1740774506073463 |
0.308 |
|
| 2006 |
McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 48: 889-96. PMID 17162143 DOI: 10.1053/J.Ajkd.2006.09.003 |
0.316 |
|
| 2006 |
Blankenberg S, Yusuf S. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets? Circulation. 114: 1557-1560. PMID 17030701 DOI: 10.1161/Circulationaha.106.652081 |
0.375 |
|
| 2006 |
Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 368: 1096-105. PMID 16997664 DOI: 10.1016/S0140-6736(06)69420-8 |
0.325 |
|
| 2006 |
Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes. The New England Journal of Medicine. 355: 1551-62. PMID 16980380 DOI: 10.1056/Nejmoa065061 |
0.325 |
|
| 2006 |
Dagenais GR, Pogue J, Teo KK, Lonn EM, Yusuf S. Impact of ramipril on the circadian periodicity of acute myocardial infarction. The American Journal of Cardiology. 98: 758-60. PMID 16950179 DOI: 10.1016/J.Amjcard.2006.03.061 |
0.392 |
|
| 2006 |
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 114: 774-82. PMID 16908769 DOI: 10.1161/Circulationaha.106.612812 |
0.389 |
|
| 2006 |
Fox K, Ferrari R, Yusuf S, Borer JS. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and ‘preserved’ left ventricular function? European Heart Journal. 27: 2154-2157. PMID 16905555 DOI: 10.1093/Eurheartj/Ehl122 |
0.4 |
|
| 2006 |
Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials The Lancet. 368: 581-588. PMID 16905022 DOI: 10.1016/S0140-6736(06)69201-5 |
0.432 |
|
| 2006 |
Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. American Heart Journal. 152: 223-30. PMID 16875901 DOI: 10.1016/J.Ahj.2006.05.019 |
0.384 |
|
| 2006 |
Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 114: 201-8. PMID 16831981 DOI: 10.1161/Circulationaha.105.590927 |
0.351 |
|
| 2006 |
Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, Lee KL, Skene AM, Schron EB, Skehan JD, Goldman L, Roberts RS, Camm AJ, Yusuf S, Connolly SJ. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 114: 11-17. PMID 16801463 DOI: 10.1161/Circulationaha.105.610303 |
0.411 |
|
| 2006 |
Eisenstein EL, Yusuf S, Bindal V, Bourassa MG, Horney A, Collins JF, Mark DB. What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial Journal of Cardiac Failure. 12: 336-342. PMID 16762794 DOI: 10.1016/J.Cardfail.2006.04.002 |
0.323 |
|
| 2006 |
Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. Journal of the American College of Cardiology. 47: 1997-2004. PMID 16697316 DOI: 10.1016/J.Jacc.2006.01.060 |
0.376 |
|
| Show low-probability matches. |